Prof.

SILVA Mario

Ricercatore a tempo determinato
Settore scientifico disciplinare
DIAGNOSTICA PER IMMAGINI E RADIOTERAPIA (MED/36)
  • Curriculum Vitae
  • Orario di ricevimento
  • Insegnamenti
  • Incarichi
  • Ricerca
  • Terza Missione

GENERAL INFORMATION

  • First name: Mario 
  • Last name: Silva
  • Born in Parma (Italy), September 24, 1983
  • Married, two daughters, one son
     

Referees

Nicola Sverzellati, MD, PhD Professor of Radiology, Section of Diagnostic Imaging, Department of Surgical Sciences, University of Parma, Italy
Alexander A. Bankier, MD, PhD Professor of Radiology, University of Massachusetts Medical School, Worcester MA 01655
Ugo Pastorino, MD Scientific Director of MILD, bioMILD, and SMILE Lung Cancer Screening Trials, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy
Sundeep M Nayak, MD Senior Physician, Department of Radiology, Kaiser Permanente Northern California, San Leandro, CA, USA


EDUCATION 
Education in Medicine and Radiology

  1. 2002 – 2008 Medical School, graduation 110/110 “cum laude” at University of Parma (IT);
  2. 2007 – 2009 Internship in Radiology at the University of Parma (Chief Prof. M. Zompatori) (IT);
  3. 2009 Medical Board exam habilitation at University of Parma (IT);
  4. 2009 – 2014 Trainee in Diagnostic Imaging School at the University of Parma (IT), graduated in Diagnostic Imaging in July 2014.
  5. 2010 Course of Cardiac CT for Trainees: “IV Corso Residenziale di Cardio TC per Specializzandi”. Coordinator: Cademartiri F, MD, PhD. Azienda Ospedaliero-Universitaria di Parma (IT);

Personal Interests

  • Family, sports (basketball, motorbike, windsurf, ski, tennis), social life (formerly boy scout), travelling.
     

CLINICAL CAREER 
 Clinical Expertise

Main expertise in Pulmonary, Cardiac, Vascular, Oncologic, and Emergency Imaging.

  • 2014 – present Consultant Radiologist at the University Hospital of Parma.
  • 2014 – present Consultant Radiologist in the Multidisciplinary Team of Thoracic Oncology at the University Hospital of Parma (weekly multidisciplinary discussion » 15-30 cases/week)
  • 2017 – 2018 “Perfect project” online platform for multidisciplinary discussion and second opinion for diagnosis of interstitial lung disease (ILD)
  • 2019 – present Consultant Radiologist in the Multidisciplinary Team of Thoracic Disease at the University Hospital of Parma (weekly multidisciplinary discussion » 10-15 cases/week)
  • 2020 Consultant Thoracic Radiologist in the local Radiological Task Force “COVID-19 protocol” for adaptive management and data analysis at the University Hospital of Parma, during SARS-CoV-2 pandemic.

Clinical Certification

  • 2018-2023 Basic Life Support - Defibrillation (BLS-D) certificate according to America Heart Association (AHA - https://www.heart.org )
  • 2018-2024 Good Clinical Practice (GCP) certificate by the NIDA Clinical Trials Network (https://gcp.nidatraining.org )
  • 2019-2021 Advanced Cardiovascular Life Support (ACLS) certificate according to America Heart Association (AHA - https://www.heart.org )
  • April 2021 – present subscription and attendance at the “Master di Formazione per Direzione di UOC di Radiologia” issued by Società Italiana di Radiologia Medica (SIRM)
  • September 2021 – present subscription and attendance at the “Aggiornamento formativosulle esposizioni mediche - CORSOSIRM-AIFM-AIRM D.Lgs.101/20” issued by Società Italiana di Radiologia Medica (SIRM)
     

ACADEMIC CAREER
 Fellowships

  • 2010 – present Research Fellow in lung cancer screening trial at the Multicenter Italian Lung Detection (MILD and bioMILD), Fondazione IRCCS Istituto Nazionale Tumori (INT, Milan, Italy); 
  • 2011 – 2012 Trainee in Cardio-Vascular Imaging at the Diagnostic Imaging Department of Policlinico S. Orsola-Malpighi (Bologna, IT);
  • 2013 Research Fellow in Cardiothoracic Imaging at Beth Israel Deaconess Medical Center (BIDMC, Harvard Medical School, Boston, MA, USA)
  • 2014 – 2018 Reading Radiologist in lung cancer screening at the MILD and bioMILD trials at Istituto Nazionale dei Tumori di Milano (screening low-dose computed tomography read: > 10,000).
  • 2020 – present Associate Researcher at the Institute for Diagnostic Accuracy Consulting B.V. (iDNA) in the field of lung cancer screening and early diagnosis of smoking related lung disease and cardiovascular risk factors

Academic Positions

  • 2014-2017 – Doctorate in Surgical Sciences and Applied Microbiology at the University of Parma (IT). Title of PhD thesis: “Diagnosis and Follow-up of Oncologic and Vascular Pathology of Surgical Interest: The Role of Diagnostic Imaging”.
    Date of PhD defense: March 15, 2017
  • 2015 – 2020 Assistant Professor at the University of Parma, Department of Surgical Sciences [RTD art. 24 lettera a), legge n. 240 del 30 dicembre 2010; SC 06/I1, SSD MED/36 Diagnostic Imaging and Radiation Therapy].
  • 2018 – Certification for Associate Professorship issued by the National Scientific Review Board (Abilitazione Scientifca Nazionale – ASN – alle funzioni di Professore Universitario di II Fascia dal 02/10/2018 al 02/10/2024 art. 16, comma 1, Legge 240/10 – Official publication at https://asn16.cineca.it/pubblico/miur/esito-abilitato/06%252FI1/2/5 ) – See “Attachment 1”.
  • 2020 – present Vice President of the Degree course in IMAGING AND RADIOTHERAPY TECHNIQUES, University of Parma
  • 2021 - Assistant Professor at the University of Parma, Department of Surgical Sciences [RTD art. 24 lettera b), legge n. 240 del 30 dicembre 2010; SC 06/I1, SSD MED/36 Diagnostic Imaging and Radiation Therapy].
  • 2021 – Adjunct Assistant Professor at the University of Massachusetts, Department of Radiology in the TH Chan School of Medicine at the UMAss Chan Medical School (Worcester, MA, USA).

Teaching Assignments

  • 2016 – present Chief of teaching course and Official teaching assignment: OPERATING PROTOCOLS MAGNETIC RESONANCE AND COMPUTED TOMOGRAPHY; Degree course in IMAGING AND RADIOTHERAPY TECHNIQUES, University of Parma
  • 2017 – present Residency Program in Diagnostic Imaging at the University of Parma
  • 2017 – present Official teaching assignment: DIAGNOSTICS OF IMAGES AND RADIOLOGY; Master Degree in MEDICAL SCHOOL, University of Parma
  • 2018 – present Official teaching assignment: DIAGNOSTICS OF IMAGES AND RADIOLOGY; Master Degree in DENTIST SCHOOL, University of Parma

Academic Activity

  • Students and trainees mentoring 
  • Responsibility of degree thesis for:
    • Master Degree in MEDICAL SCHOOL
    • Degree course in IMAGING AND RADIOTHERAPY TECHNIQUES
    • Residency Program in Diagnostic Imaging
  • Manager of International exchange program at the Section of Radiology, Department of Medicine and Surgery (DiMeC) at the Univeristy of Parma:
    • 2019 Visiting Professor: Sundeep M Nayak, MD, Senior Physician, The Permanente Medical Group, Inc. – San Leandro, California
  • Committee member and Secretariat in several competitions for Academic positions
  • Invited Faculty:
    • University of Padova, Italy – Host Faculty: Prof. Paolo Spagnolo
      Residency Program in Pulmonology. Symposium: “Lung cancer screening and clinical management of lung nodule”. December 20, 2020 – Padova (IT)
    • University of Massachusetts Medical Center and University of Massachusetts Medical School, Massachusetts (USA) – Host Faculty: Prof. Max Rosen and Prof. Alexander Bankier
      • Residency Program in Radiology “Difficulties in ILD imaging: IPF vs CHP”. November 20, 2020 – Online and Worcester (MA)
      • 13th Annual Edward Smith Lecture “Living through Covid -19 in Northern Italy – views from a radiologist, physician, and citizen”. June 10, 2020 – Online and Worcester (MA)
  • International Doctorate:
    • University of Groningen, The Netherlands
      Role: Opposition committee in PhD Defense (June 22, 2021)
      Candidate: Sunyi Zheng

Awards

  1. 2014 RSNA Introduction to Research for International Young Academics (IRIYA) Program, sponsored by the Committee on International Radiology Education (CIRE).
  2. 2015 The Outstanding Young Person (TOYP) Prize in Category “Research” organized by the Junior Chamber International (JCI), Parma Section, Italy.
  3. 2015 “Premio Luigi Pigorini” National award to proficient scientific production in Thoracic Imaging, for Radiologists under the age of 40 – Società Italiana di Radiologia medica (SIRM), Section of Thoracic Imaging.
  4. 2017 European Congress of Radiology (ECR 2017, March 1-5 – Vienna, Austria): Best Scientific Paper Presentation Award 2017 within the topic "Chest"
    Awarded presentation: “Subsolid and Part-Solid Nodules in Lung Cancer Screening: Comparison Between Visual and Computer-Aided Detection” Silva M, Capretti G, Sverzellati N, Jacobs J, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Marchianò A, Pastorino U.
  5. 2017 54th National Congress of the Italian Society of Rheumatology (SIR – November 22-25, Rimini, Italy) Awarded poster: “Quantification of Interstitial Lung Disease in Sjogren Syndrome” Ariani A, Silva M, Martin Garrido, Martin Segarra O, Santilli D, Mozzani F, Luque Pinilla JM, Sverzellati N, Guisado Vasco P.
  6. 2017 Journal of Thoracic Imaging’ (JTI) Editor’s Recognition Award for Distinction in Reviewing in 2017, as noted in the January 2018 issue of the journal.
  7. 2018 Journal of Thoracic Imaging’ (JTI) Editor’s Recognition Award for Distinction in Reviewing in 2018, as noted in the January 2019 issue of the journal.

SCIENTIFIC ACTIVITY

Scopus Author ID: 56335785800 http://www.scopus.com/authid/detail.uri?authorId=56335785800
Web of Science ResearcherID: B-9509-2016  http://www.researcherid.com/rid/B-9509-2016
ORCID: 0000-0002-2538-7032 http://orcid.org/0000-0002-2538-7032
ResearchGate: https://www.researchgate.net/profile/Mario_Silva12/
Google Scholar: http://scholar.google.it/citations?user=gzM0B_QAAAAJ&hl=en

National And International Scientific Collaborations

  1. 2010 – ongoing  Fondazione IRCCS Istituto Nazionale dei Tumori (INT) – Milan, Italy
  2. 2014 – 2016  Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School – Boston (MA), Unites States of America
  3. 2014 – ongoing  Radboud University Medical Center – Nijmegen, The Netherlands
  4. 2017-2019 University of Brescia – Brescia, Italy
  5. 2018 – ongoing  Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF), Faculty of Medicine and Health, The University of Sydney, Royal Prince Alfred Hospital – Camperdown, Australia
  6. 2020 – present Institute for Diagnostic Accuracy Consulting B.V. (iDNA) awarded an EU project (4-in-the-lung-run) in the field of lung cancer screening and early diagnosis of smoking related lung disease and cardiovascular risk factors
  7. 2021 – present University of Twente (The Netherlands) leading the multicenter project “Preference study for Big-3 Screening”
  8. 2021 – present Invited Adjunct Faculty at the University of Massachusetts Medical Center and University of Massachusetts Medical School, Massachusetts (USA)
     

Grants

  1. 2016 – ESTI Experienced Chest Radiology Researchers Grant – European Society of Thoracic Imaging (ESTI).
    Project title: “Information From Computed Tomography Follow-Up in Idiopathic Pulmonary Fibrosis: iPFBC Multicenter Pooled Comparison With Clinical and Functional Metrics”
    Role: Principal Investigator
    Funding: 7,500 euros
  2. 2019 – Italian Foundation for Cancer Research (Associazione Italiana per la Ricerca sul Cancro, AIRC) Investigator Grant - IG 2019
    Project title: “A Radio-Immuno-Genomic Approach to Identify Prognostic and Predictive Models for the Response to Immunotherapy in NSCLC” – PI: Prof. Nicola Sverzellati (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Grant ID: 23606
    Role: Experienced researcher
    Funding: 1,119,000 euros
  3. 2019 – Fondazione Cariparma
    Project title: “Progetto Salute Parma (PSP): Prevenzione Primaria e Secondaria del Danno da Fumo” (Primary and Secondary Prevention (PSP) of Smoking Related Damage: Parma Project) – PI: Prof. Nicola Sverzellati (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Grant ID: 0166/2019
    Role: Scientific collaborator
    Funding: 139,000 euros
  4. 2020 – University of Parma “Bando straordinario di Ateneo per progetti di ricerca biomedica in ambito SARS-CoV-2 e COVID-19”
    Project title: “Morbilità e mortalità da Covid-19 nel diabete mellito di tipo 2: possibile ruolo del macrofago e impatto di farmaci anti-diabete” – PI: Prof. Riccardo Bonadonna (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Role: Scientific collaborator
  5. 2020 – Swiss National Science Foundation (SNSF), National Research Programme (NRP) 78 entiteld “COVID-19”
    Project title: “AI-multi-omics-based Prognostic Stratification of COVID-19 Patients in Acute and Chronic State” – PI: Alexander Pollinger (Inselspital Bern, University of Bern, Bern, Switzerland)
    Role: Scientific collaborator
    Funding: 617,665 CHF
  6. 2020 – Italian Ministry of Health, BANDO RICERCA FINALIZZATA 2019 
    Project title: “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth (PEOPLHE)” – PI: Prof. Nicola Sverzellati (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Role: Research team
    Funding: 449,940 euro

Clinical TrialsLung Cancer Screening by Low-Dose Computed Tomography

  1. MILD: Multicentric Italian Lung Detection (ClinicalTrials.gov Identifier: NCT02837809)
  2. bioMILD:  Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study (ClinicalTrials.gov Identifier: NCT02247453)
  3. SMILE: Screening and Multiple Intervention on Lung Epidemics (ClinicalTrials.gov Identifier: NCT03654105)
  4. PSP: Progetto Salute Parma: Prevenzione Primaria e Secondaria del Danno da Fumo (Primary and Secondary Prevention (PSP) of Smoking Related Damage: Parma Project) (ClinicalTrials.gov Identifier: NCT04282694)
  5. PEOPLHE: Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth

Thoracic Oncology

  1. EORTC (European Organisation for Research and Treatment of Cancer) Lung Cancer Group)
    1. Study 1417: “REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer”
      (EudraCT number:  2014-003090-42) 
    2. Study 1613: “APPLE: Feasibility and activity of AZD9291 treatment on Positive PLasma T790M in EGFR mutant NSCLC patients”
      (EudraCT number: 2016-001834-82)
    3. Study 1525: “Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemotherapy – Nivothym”
      (EudraCT number: 2015-005504-28)
  2. PARMA: Progetto AIRC Ricerca Multiomica Avanzata (A Radio-Immuno-Genomic Approach to Identify Prognostic and Predictive Models for the Response to Immunotherapy in NSCLC) (ClinicalTrials.gov registration underway)

Oncohematology 

  1. ACE-CL-007: Elevate CLL TN: Study of Obinutuzumab + Chlorambucil, Acalabrutinib (ACP-196) + Obinutuzumab, and Acalabrutinib in Subjects With Previously Untreated CLL (ClinicalTrials.gov Identifier: NCT02475681)
  2. ACE-LY-308: A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma (ClinicalTrials.gov Identifier: NCT02972840)
  3. 20130109: Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab (JASMINE) (ClinicalTrials.gov Identifier: NCT02747043)
  4. CC-5013-NHL-007: Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) (AUGMENT) (ClinicalTrials.gov Identifier: NCT01938001)
  5. GS-US-313-1580: Dose Optimization Study of Idelalisib in Follicular Lymphoma (ClinicalTrials.gov Identifier: NCT02536300)
  6. B-MIND: A Trial to Evaluate the Efficacy and Safety of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (ClinicalTrials.gov Identifier: NCT02763319)
  7. PCYC-1141-CA: Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma (ClinicalTrials.gov Identifier: NCT02947347)
  8. B3281006: A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) (ClinicalTrials.gov Identifier: NCT02213263)

Development Of Quantitative Imaging And Artificial Intelligence

  1. 2013 – present Pulmo3D and Airway Examiner, MeVis - Fraunhofer, Germany
  2. 2013 – 2016 Parametric Response Map (PRM) for COPD phenotyping, Imbio - Minneapolis, MN
  3. 2013 – present Quantitative Imaging Biomarkers Alliance (QIBA), Committee “QIBA Lung Density Biomarker” http://qibawiki.rsna.org/index.php/Lung_Density_Biomarker_Ctte
  4. 2014 – present CIRRUS Lung Screening, CAD system for detection and quantification of lung nodules – Radboud University Medical Center, Nijmegen, Netherlands
  5. 2014 – 2015 OraMod European project, Mutidisciplinary platform for comprehensive management of oral cancer “Imaging platform for quantitative analysis and standardized staging” – Imaging developers the Fraunhofer Institute for Computer Graphics IGD in Darmstadt (DE) and the Univeristy of Parma (IT).
  6. 2016 – 2019 BD2Decide project: A Prospective Observational Study for the Development and Validation of New Prognostic Models in Head and Neck Cancer Patients for Decision Support. 
    European Commission funded projects within the program “Horizon2020”, accessible within the Community Research and Development Information Servive (CORDIS): http://cordis.europa.eu/project/rcn/200298_en.html 
    H2020-PHC-2015-689715 BD2Decide
  7. 2017 – present Quantitative Imaging Biomarkers Alliance (QIBA), Commitee  “CT Small Lung Nodule Biomarker” http://qibawiki.rsna.org/index.php/CT_Small_Lung_Nodule_Biomarker_Ctte
  8. 2020 – present Institute for Diagnostic Accuracy Consulting B.V. (iDNA) awarded an EU project (4-in-the-lung-run) in the field of lung cancer screening and early diagnosis of smoking related lung disease and cardiovascular risk factors.

Membership Of Scientific Societies

  1. Ordinary member of the Italian Society of Radiology (SIRM), Sections of Thoracic Imaging and Cardiovascular Imaging, since 2009
  2. Elected delegate of “Young Radiologists” for the Regional Group of SIRM in Emilia-Romagna 2012-2013.
  3. Ordinary member of the European Society of Radiology since 2012 
  4. Ordinary member of the European Society of Thoracic Imaging (ESTI) since 2012 
  5. Junior member of the Radiology Society of North America (RSNA) since 2013
  6. Ordinary member of Quantitative Imaging Biomarkers Alliance (QIBA) “COPD/Asthma” and “Lung Nodule assessment in CT screening” section at RSNA since 2013, and “CT Small Lung Nodule Biomarker Ctte” since 2018
  7. Silver Under 35 member of European Respiratory Society (ERS) since 2014
  8. European Organization for Reasearch and Treatment of Cancer (EORTC – Lung Section) since 2015
  9. Board member of the European Society of Thoracic Imaging (ESTI), “Social Media Committee” (formerly “Electronic Media Committee”) (http://esti.gr4fix.net/committee/) since 2017

Membership Of Scientific Committees

  1. European Society of Radiology (ESR): e-Learning committee “Chest Imaging” (role: Content lead) since 2018.
  2. European Society of Thoracic Imaging (ESTI): Lung cancer screening (LCS) certification project since 2019 (role: structured report, workshops). 
    URL: https://www.myesti.org/lungcancerscreeningcertificationproject/
  3. European Society of Thoracic Imaging (ESTI) representative (aka: Subspecialty Society Delegate) in the European Society of Radiology (ESR) Research Committee since 2020.

International Guidelines Committee

1.     European Society of Radiology (ESR) and European Respitatory Society (ERS) white paper on Lung Cancer Screening. Chapters assigned: 
i - Italian experience: Bonomo L, Silva M
ii - Overdiagnosis: Silva M, Brodersen J, Gaga M, Bostantzoglou N, Revel MP
iii - Biomarkers for lung cancer: Silva M, Blum T, Peled N, Gaga M

Editor For International Scientific Journals

1.     European Journal of Radiology (ISSN: 0720-048X):
i - Section Editor of “Chest Imaging” since 2018 (impact factor 2.462)
ii - Lead Editor of Section “Chest Imaging” since 2021 (impact factor 2.687)
URL: https://www.ejradiology.com/content/edboard

2.     Tumori Journal (ISSN: 0300-8916): Section Editor of “Imaging Section” since 2019 (impact factor 1.304) – URL: https://journals.sagepub.com/editorial-board/tmj

3.     British Journal of Radiology (ISSN: 0007-1285): Associate Editor of “Respiratory/Chest Diagnostics” since 2020 (impact factor 1.939) – URL: https://www.birpublications.org/page/editorialboard/bjr 
 

Reviewer For International Authorities

1.      Appointed peer reviewer by Cancer Research UK ( https://www.cancerresearchuk.org ), for the specific task of Early Detection Research Committee:

a.      Application Title: “ASCENT: Analysis of screen-detected lung cancers genomic traits”
Application Reference: C9429/A28706

2.     Interface Politikstudien Forschung Beratung GmbH ( https://www.interface-pol.ch/en ): appointed as “Italian expert” in International survey for planning of Lung Cancer Screening at population level in Switzerland

Reviewer For International Scientific Journals

  1. “Respiration” (ISSN: 0025-7931) since 2013 (impact factor 2.651);
  2. “COPD: Journal Of Chronic Obstructive Pulmonary Disease” (ISSN: 1541-2555) since 2013 (impact factor 2.673);
  3. “BMC Musculoskeletal Disorders” (ISSN: 1471-2474) since 2014 (impact factor 1.941);
  4. “Chest” (Print ISSN: 0012-3692; Online ISSN: 1931-3543) since 2014 (impact factor 5.94);
  5. “Journal of Thoracic Imaging” (Print ISSN: 0883-5993; Online ISSN: 1536-0237) since 2014 (impact factor 1.723);
  6. “Tumori Journal” (ISSN: 0300-8916) since 2015 (impact factor 1.071);
  7. “Cancer Imaging” (ISSN: 1470-7330) since 2015 (impact factor 1.470);
  8. “European Radiology” (Print ISSN: 0938-7994; Online ISSN: 1432-1084) since 2015 (impact factor 3.640);
  9. “QJM: an International Journal of Medicine” (Print ISSN 1460-2725; Online ISSN 1460-2393) since 2015 (impact factor 2.634);
  10. “Eurorad” brought by the European Society of Radiology ( https://www.eurorad.org/about-us ) since 2016.
  11. “Acta Radiologica” (Print ISSN: 0284-1851; Online ISSN: 1600- 0455) since 2016 (impact factor 2.009);
  12. “BMC Pulmonary Medicine” (ISSN: 1471-2466) since 2017 (impact factor 2.329);
  13. “European Journal of Radiology” (ISSN: 0720-048X) since 2017 (impact factor 2.462);
  14. “Investigative Radiology” (ISSN: 0020-9996; Online ISSN: 1536-0210) since 2018 (impact factor 5.195);
  15. “International Journal of Tuberculosis and Lung Disease (IJTLD)” (ISSN: 1027-3719; Online ISSN: 1815-7920) since 2018 (impact factor 2.468);
  16. “British Medical Journal Open (BMJ Open)” (Online ISSN: 2044-6055) since 2018 (impact factor 2.413);
  17. “European Respiratory Journal (ERJ)” (ISSN: 0903-1936; Online ISSN: 1399-3003) since 2018 (impact factor 12.242). 
  18. “Lung Cancer” (ISSN: 0169-5002) since 2019 (impact factor 4.486).
  19. “British Journal of Radiology” (ISSN: 0007-1285) since 2019 (impact factor 2.050).
  20. “Respiratory Medicine” (ISSN: 0954-6111) since 2019 (impact factor 3.230).
  21. “Radiology” (ISSN: 0033-8419) since 2019 (impact factor 7.469).
  22. “BMC Cancer Communications” (ISSN: 2523-3548) since 2019 (impact factor 3.644).
  23. “Cancer epidemics” (ISSN: 1877-7821) since 2019 (impact factor 2.619).
  24. “American Journal of Respiratory and Critical Care Medine – AJRCCM” (ISSN: 1073-449X; Online ISSN: 1535-4970) since 2019 (impact factor: 16.494).
  25. “Academic Radiology” (ISSN: 1878-4046) since 2019 (impact factor: 2.267).
  26. “BMC Family Practice” (ISSN‎: ‎1471-2296) since 2019 (impact factor: 2.666).
  27. “Respirator Reaserch” (ISSN:  1465-993X) since 2019 (IF: 3.829).
  28. “The Lancet Digital Health” (ISSN: 2589-7500) since 2020.
  29. “BMC Infectious disease” (ISSN: 1471-2334) since 2020 (IF: 2.580).
  30. “Annals of Oncology” (ISSN: 0923-7534) since 2020 (IF: 18.274).
  31. “Cancers” (ISSN: 2072-6694) since 2021 (IF: 6.126)
  32. “Respiratory Investigation” (ISSN: 2212-5345) since 2021 (IF: 1.64)

Editor Of Book

  1. Cancer Dissemination Pathways (Series ISSN 2510-3474): The Thorax (1st ed. 2020 Edition) – Sverzellati N, Silva M Editors (Springer; eBook ISBN 978-3-030-27233-3; hardcover ISBN 978-3-030-27232-6) https://www.springer.com/gp/book/9783030272326

Author Of Book Chapters

  1. Radiologia Medica collections 2010 – Corso Monotematico di radiologia Toracica
    Authors: Sverzellati N, Silva M, Zompatori M. Chapter: BOOP and other interstitial lung diseases.
  2. Patologia Toracica di Interesse Chirurgico - Monte Università Parma Editore 2011 – Parma – Italia – IMAGING DELLA PATOLOGIA NEOPLASTICA DEL TORACE 
    Authors: Di Lauro E, Silva M, Rossi C, Buttarelli L, Sverzellati N.
  3. Atlas of Diffuse Lung Diseases – A Multidisciplinary Approach – Dalpiaz G, Cancellieri A Editors (Springer; ISBN 3319427504) – Chapters “Septal Disease” and “Nodular Disease” 
    Authors: Sverzellati N, Silva M
  4. Bronchiectasis. The EMBARC Manual – Chalmers JD, Polverino E, Aliberti S Editors (Springer; ISBN 978-3-319-61451-9; ISBN e-book: 978-3-319-61452-6) https://doi.org/10.1007/978-3-319-61452-6 – Chapter “Imaging of Bronchiectasis” 
    Authors: Silva M, Milanese G, Sverzellati N. 
  5. ESC Textbook of Cardiovascular Medicine 3rd edition – Luscher T, Camm J, Maurer G, Serruys P Editors (Oxfor University Press) – Section 009: Chest radiography, Chapter “Focal abnormalities” Authors: Milanese G, Silva M, Sverzellati N.
  6. Cancer Dissemination Pathways (Series ISSN 2510-3474): The Thorax (1st ed. 2020 Edition) – Sverzellati N, Silva M Editors (Springer; eBook ISBN 978-3-030-27233-3; hardcover ISBN 978-3-030-27232-6) https://www.springer.com/gp/book/9783030272326
    1. Chapter 2: “Radiological Signs of Tumor Dissemination” – Authors: Beer L, Oberndorfer F, Silva M, Prosch H
    2. Chapter 7: “Other Mediastinal Tumors” – Authors: Milone F, Taronna G, Gnetti L, Silva M
  7. Malattie dell’apparato respiratorio – Pneumologia e Chirurgia Toracica 2nd Edition – Loizzi M, Oliaro A. Ed. Minerva Medica – Chapter “La TC del torace nello screening del tumore polmonare”
    Authors: Cardianle L, Stranieri G, Chiado’ A, Silva M
  8. Grainger & Allison's Diagnostic Radiology 7th Edition (Elsevier; Hardcover ISBN 9780702075247; eBook ISBN 9780702075612– 9780702075629) – Adam A, Dixon A, Gillard J, Schaefer-Prokop CM Editors – Section “Chest and Cardiovascular System”, Chapter 9 “High-Resolution Computed Tomography of Interstitial and Occupational Lung Disease” – Authors Silva M, Sverzellati N
     

Published Scientific Articles

PubMed link: https://www.ncbi.nlm.nih.gov/sites/myncbi/1nEPeKtxjp95V/bibliography/47785154/public/?sort=date&direction=ascending

h-index: 20 (source: Scopus https://www.scopus.com/authid/detail.uri?authorId=56335785800 )

  1. Silva M, Sverzellati N, Manna C, Negrini G, Marchianò A, Zompatori M, Rossi C, Pastorino U. Long-term surveillance of ground-glass nodules: evidence from the MILD trial. J Thorac Oncol. 2012 Oct;7(10):1541-6. 
    doi: 10.1097/JTO.0b013e3182641bba
  2. De Filippo M, Castagna A, Steinbach SL, Silva M, Concari G, Pedrazzi G, Pogliacomi F, Sverzellati N, Petriccioli D, Vitale M, Ceccarelli F, Zompatori M, Rossi C. Reproducible Noninvasive Method for Evaluation of Glenoid Bone Loss by Multiplanar Reconstruction Curved Computed Tomographic Imaging Using a Cadaveric Model. Arthroscopy. 2013 Mar;29(3):471-7. 
    doi: 10.1016/j.arthro.2012.10.017
  3. Sverzellati N, Randi G, Spagnolo P, Marchianò A, Silva M, Kuhnigk JM, La Vecchia C, Zompatori M, Pastorino U. Increased mean lung density: Another independent predictor of lung cancer? Eur J Radiol. 2013 Aug;82(8):1325-31. 
    doi: 10.1016/j.ejrad.2013.01.020
  4. Sverzellati N, Colombi D, Randi G, Pavarani A, Silva M, Walsh SL, Pistolesi M, Alfieri V, Chetta A, Vaccarezza M, Vitale M, Pastorino U. Computed tomography measurement of rib cage morphometry in emphysema. PLoS One. 2013 Jul 31;8(7):e68546. 
    doi: 10.1371/journal.pone.0068546
  5. Colombi D, Di Lauro E, Silva M, Manna C, Rossi C, De Filippo M, Zompatori M, Ruffini L, Sverzellati N. Non-small cell lung cancer after surgery and chemoradiotherapy: follow-up and response assessment. Diagn Interv Radiol. 2013 Nov-Dec;19(6):447-56.
    doi: 10.5152/dir.2013.12021
  6. Ariozzi I, Paladini L, Gnetti L, Silva M, Colombi D, De Filippo M, Sverzellati N. Computed tomography-histologic correlations in lung cancer. Pathologica 2013 Dec; 105(6):329-36. Review. 
    PMID: 24730336
  7. Litmanovich D, Hartwick K, Silva M, Bankier AA.  Multidetector CT imaging in COPD: emphysema and airways assessment. Radiol Clin North Am. 2014 Jan;52(1):137-54. 
    doi:10.1016/j.rcl.2013.09.002
  8. Shahrzad M, Le TSM, Silva M, Bankier AA, Eisenberg RL. Anterior mediastinal masses. AJR Am J Roentgenol. 2014 Aug;203(2):W128-38. 
    doi: 10.2214/AJR.13.11998
  9. De Filippo M, Saba L, Silva M, Zagaria R, Concari G, Nizzoli R, Bozzetti C, Tiseo M, Ardizzoni A, Lipia S, Paladini I, Macarini L, Carrafiello G, Brunese L, Rotondo A, Rossi C. CT-guided biopsy of pulmonary nodule: is pulmonary hemorrhage a complication or an advantage? Diagn Interv Radiol 2014. 
    doi: 10.5152/dir.2014.14019
  10. Silva M, Sabato M, Valentino M, Murrone S and Sverzellati N (2014) Unusual Findings of Langerhans Cell Histocytosis in a Young Asymptomatic Patient: Case Report. J Pulm Respir Med 4:188. 
    doi: 10.4172/2161-105X.1000188 Not indexed in PubMed
  11. Ariani A, Lumetti F, Silva M, Santilli D, Mozzani F, Delsante G, Sverzellati N. Systemic sclerosis interstitial lung disease evaluation: comparison between semiquantitative and quantitative CT assessments. J Biol Regul Homeost Agents. 2014 Jul-Sep;28(3):507-13. 
    PMID: 25316138
  12. Nemec SF, Molinari F, Dufresne V, Gosset N, Silva M, Bankier AA. Comparison of Four Software Packages for CT Lung Volumetry in Healthy Individuals. Eur Radiol. 2015 Jun;25(6):1588-97. 
    doi: 10.1007/s00330-014-3557-3
  13. Pastorino U, Silva M.  Refining Strategies to Identify Populations to Be Screened for Lung Cancer. Thoracic Surgery Clinics. Published Online: February 17, 2015. 
    doi: 10.1016/j.thorsurg.2014.11.005
  14. Silva M, Nunes H, Valeyre D, Sverzellati N. Imaging of Sarcoidosis. Clin Rev Allergy Immunol. 2015 Aug;49(1):45-53. 
    doi: 10.1007/s12016-015-8478-7
  15. Ariani A, Silva M, Bravi E, Saracco M, Parisi S, De Gennaro F, Lumetti F, Idolazzi L, Seletti V, Caramaschi P, Benini C, Bodini FC, Scirè CA, Lucchini G, Santilli D, Mozzani F, Imberti D, Arrigoni E, Delsante G, Pellerito R, Fusaro E, Sverzellati N. Operator-independent Quantitative Chest Computed Tomography Versus Standard Assessment of Interstitial Lung Disease related to Systemic Sclerosis: a Multi-Centric Study. Mod Rheumatol. 2015 Sep;25(5):724-30. 
    doi: 10.3109/14397595.2015.1016200
  16. DuBrock HM, Bankier AA, Silva M, Litmanovich DE, Curry MP, Washko GR. Pulmonary vessel cross-sectional area before and after liver transplantation: quantification with computed tomography. Acad Radiol. 2015 Jun;22(6):752-9. 
    doi: 10.1016/j.acra.2015.01.018
  17. Colombi D, Manna C, Montermini I, Seletti V, Diciotti S, Tiseo M, Fontana E, De Filippo M, Silva M, Sverzellati N. Semiautomatic Analysis on CT scan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Reproducibility and Prognostic Significance of Uni-dimensional and Three-Dimensional Measurements. J Thorac Imaging. 2015 Sep;30(5):290-9. 
    doi: 10.1097/RTI.0000000000000145
  18. De Filippo M, Saba L, Negrini G, Silva M, Pedrazzi G, Pogliacomi F, Castagna A. Inter-observer agreement of CT measurement of the glenoid bone surface by the CT Pico method: Comparison with laser in a cadaveric model. Skeletal Radiol. 2015 Oct;44(10):1491-7. 
    doi: 10.1007/s00256-015-2199-0
  19. Silva M, Bankier AA, Centra F, Colombi D, Ampollini L, Carbognani P, Sverzellati N. Longitudinal Evolution of Incidentally Detected Solitary Pure Ground-Glass Nodules on CT: Relation to Clinical Metrics. Diagn Interv Radiol (Ank). 2015 Jul 3. 
    doi: 10.5152/dir.2015.14457
  20. Walsh SLF , Calandriello L, Sverzellati N, Hansell DM on behalf of The UIP Observer Consort (Collaborators include Silva M). Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT. Thorax 2015;0:1–7. 
    doi: 10.1136/thoraxjnl-2015-207252.
  21. Lumetti F, Barone L, Alfieri C, Silva M, Serra V, Delsante G, Sverzellati N, Ariani A. Quality of Life and Functional Disability in Patients with Interstitial Lung Disease Related to Systemic Sclerosis. Acta Biomed. 2015 Sep 14;86(2):142-8. 
    PMID: 26422428
  22. Silva M, Nemec S, Dufresne V, Occhipinti M, Heidinger B, Chamberlain R, Bankier AA. Normal Spectrum of Pulmonary Response Map: Distribution of Densitometric Classifications in Healthy Adult Volunteers. Eur Radiol. 2016 Sep;26(9):3063-70.
    doi: 10.1007/s00330-015-4133-1
  23. Silva M, Galeone C, Sverzellati N, Marchianò A, Calareso G, Sestini S, La Vecchia C, Sozzi G, Pelosi G, Pastorino U. Screening with Low Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer. J Thor Oncol Vol. 11 No. 2: 187-193. 
    doi:10.1016/j.jtho.2015.10.014.
  24. Milanese G, Silva M, Sverzellati N. Lung volume reduction of pulmonary emphysema: the radiologist task. Curr Opin Pulm Med. 2016 Mar;22(2):179-86. 
    doi: 10.1097/MCP.0000000000000252.
  25. Sverzellati N, Silva M, Calareso G, Galeone C, Marchianò A, Sestini S, Sozzi G, Pastorino U. Low-Dose Computed Tomography for Lung Cancer Screening: Comparison of Performance Between Annual and Biennial Screen. Eur Radiol. 2016 Nov;26(11):3821-3829. Epub 2016 Feb 11. 
    doi: 10.1007/s00330-016-4228-3
  26. Ariani A, Aiello M, Silva M, Alfieri V, Bonati E, Lumetti F, Delsante G, Sverzellati N, Chetta A. Quantitative CT Indexes Are Significantly Related To Exercise Oxygen Desaturation in Interstitial Lung Disease Related to Systemic Sclerosis. Clin Respir J. 2016 Feb 22. 
    doi: 10.1111/crj.12451
  27. Pastorino U, Boffi R, Marchianò A, Sestini S, Munarini E, Calareso G, Boeri M, Pelosi G, Sozzi G, Silva M, Sverzellati N, Galeone C, La Vecchia C, Ghirardi A, Corrao G. Stopping smoking reduces mortality in low-dose computed tomography (LDCT) screening volunteers. J Thorac Oncol. 2016 May;11(5):693-9. 
    doi: 10.1016/j.jtho.2016.02.011
  28. Milanese G, Capretti G, Sverzellati N, Silva M. Lung cancer screening: are we ready now? Shortness of Breath Vol. 5 (No. 1) 2016 January-March. 
    doi: 10.11138/sob/2016.5.1.020 Not indexed in PubMed
  29. Sestini S, Boeri M, Marchianò A, Silva M, Calareso G, Galeone C, Sozzi G, Pastorino U. Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test. Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 1):42-50. 
    doi: 10.19191/EP16.1S1.P042.029
  30. Manna C, Silva M, Gazzani SE, Cobelli R. An uncommon cause of ascites: uroperitoneum from iatrogenic bladder fistula detected by CT urography. BJR Case Rep 2016; 2: 20150391. 
    doi: 10.1259/bjrcr.20150391. Not indexed in PubMed
  31. Infante M, Sestini S, Galeone C, Marchianò A, Lutman FR, Angeli E, Calareso G, Pelosi G, Sozzi G, Silva M, Sverzellati N, Cavuto S, La Vecchia C, Santoro A, Aloisio M, Pastorino U. Lung cancer screening with low dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials. Eur J Cancer Prev. 2017 Jul;26(4):324-329. 
    doi: 10.1097/CEJ.0000000000000264
  32. Bozzetti F, Paladini I, Rabaiotti E, Franceschini A, Alfieri V, Visca D, Chetta A, Crisafulli E, Silva M, Pastorino U, Sverzellati N. Are interstitial lung abnormalities associated with COPD? A nested case-control study. Int J Chron Obstruct Pulmon Dis. 2016 May 26;11:1087-96. 
    doi: 10.2147/COPD.S103256. 
  33. Silva M, Zambrini EI, Chiari G, Montermini I, Manna C, Poli T, Lanfranco D, Sesenna E, Thai E, Sverzellati N. Pre-surgical Assessment of Mandibular Bone Invasion from Oral Cancer: Comparison Between Different Imaging Techniques and Relevance of Radiologist Expertise. Radiol Med. 2016 Sep;121(9):704-10. 
    doi: 10.1007/s11547-016-0654-1
  34. Colombi D, Ehlers-Tenenbaum S, Palmowski K, Heussel CP, Sverzellati N, Silva M, Eichinger M, Kreuter M. Spontaneous Pneumomediastinum as a Potential Predictor of Mortality in Patients with Idiopathic Pulmonary Fibrosis. Respiration. 2016;92(1):25-33. 
    doi: 10.1159/000447430
  35. Crisafulli E, Alfieri V, Silva M, Aiello M, Tzani P, Milanese G, Bertorelli G, Sverzellati N, Chetta A. Relationships Between Emphysema and Airways Metrics at High-resolution Computed Tomography (HRCT) and Ventilatory Response to Exercise in Mild to Moderate COPD Patients. Respir Med. 2016 Aug;117:207-14. 
    doi: 10.1016/j.rmed.2016.06.016
  36. Pavarani A, Martini C, Gafà V, Bini P, Silva M, Ghetti C, Sverzellati N. Effect of iterative reconstruction on image quality of low-dose chest computed tomographic examinations. Acta Biomed. 2016 Sep 13;87(2):168-176. 
    PMID: 27648999
  37. Landini N, Milanese G, Zambrini E, Ariozzi I, Gnetti L, Carloni A, Nosenzo, Silva M, Sverzellati N. Computed Tomography-Histology Correlations of Unusual Lung Tumors. Pathologica 2016;108:110-119 
    PMID: 28195262
  38. Rasciti E, Sverzellati N, Silva M, Casadei A, Attinà D, Palazzini M, Galiè N, Zompatori M. Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension. Radiol Med. 2017 Apr;122(4):257-264. 
    doi: 10.1007/s11547-016-0714-6
  39. Ariani A, Silva M, Seletti V, Bravi E, Saracco M, Parisi S, De Gennaro F, Caramaschi P, Scirè C, Idolazzi L, Benini C, Bodini F, Lumetti F, Alfieri V, Bonati E, Lucchini G, Aiello M, Santilli D, Mozzani F, Imberti D, Michieletti E, Arrigoni E, Delsante G, Pellerito R, Fusaro E, Chetta AA, Sverzellati N. Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis. Rheumatology (Oxford). 2017 Feb 4. 
    doi: 10.1093/rheumatology/kew480.
  40. Silva M, Pastorino U, Sverzellati N. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials. Clin Radiol. 2017 May;72(5):389-400. 
    doi: 10.1016/j.crad.2016.12.021
  41. Marchianò A, Cosentino M, Di Tolla G, Greco FG, Silva M, Sverzellati N, Fabbri A, Tamborini E, Lo Russo G, Mariani L, Lalli L, Pastorino U. FNA and CNB in the diagnosis of pulmonary lesions: a single-center experience on 665 patients, comparison between two periods. Tumori. 2017 Apr 28:0. 
    doi: 10.5301/tj.5000633
  42. Manna C, Silva M, Poggesi S, Cobelli R, Rossi C, Sverzellati N. High-Pitch Dual-Source CT Angiography without ECG-gating for Imaging The Whole Aorta: Intra-individual Comparison with Standard Pitch Single-Source Technique. Diagn Interv Radiol. 2017 Jul-Aug;23(4):293-299. 
    doi: 10.5152/dir.2017.16617
  43. Milanese G, Sverzellati N, Pastorino U, Silva M. Adenocarcinoma in pure ground glass nodules: histological evidence of invasion and open debate on optimal management. J Thorac Dis 2017. 
    doi: 10.21037/jtd.2017.08.120 
  44. Pellegrino B, Facchinetti F, Bordi P, Silva M, Gnetti L, Tiseo M. Lung toxicity in non-small cell lung cancer patients exposed to ALK inhibitors: report of a peculiar case and systematic review of the literature. Clin Lung Cancer. 2018 Mar;19(2):e151-e161. 
    doi: 10.1016/j.cllc.2017.10.008
  45. Silva M, Milanese G, Seletti V, Ariani A, Sverzellati N. Pulmonary Quantitative CT Imaging in Focal and Diffuse Disease: Facing Clinical and Research Application. Br J Radiol. 2018 Feb;91(1083):20170644. doi: 10.1259/bjr.20170644
  46. Silva M, Sverzellati N, Colombi D, Milanese G, La Vecchia C, Galeone C, Marchianò A, Pastorino U. Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality. BMC Pulm Med. 2017 Nov 25;17(1):155. 
    doi: 10.1186/s12890-017-0506-3 
  47. Sverzellati N, Odone A, Silva M, Polverosi R, Florio C, Cortese G, Cardinale L, Addonisio G, Zompatori M, Dalpiaz G, Piciucchi S, Larici AR et al. Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist. Radiol Med. 2018 Apr;123(4):245-253. 
    doi: 10.1007/s11547-017-0835-6 
  48. Charbonnier JP, Chung K, Scholten ET, van Rikxoort EM, Jacobs C, Sverzellati N, Silva M, Pastorino U, van Ginneken B, Ciompi F. Automatic Vessel and Solid Core Segmentation in Pulmonary Subsolid Nodules. Sci Rep. 2018 Jan 12;8(1):646. 
    doi: 10.1038/s41598-017-19101-3
  49. Silva M, Schaefer-Prokop CM, Jacobs C, Capretti G, Ciompi F, van Ginneken B, Pastorino U, Sverzellati N. Detection of Subsolid Nodules in Lung Cancer Screening: Complementary Sensitivity of Visual Reading and Computer-Aided Diagnosis. Invest Radiol. 2018 Aug;53(8):441-449. 
    doi: 10.1097/RLI.0000000000000464
  50. Sverzellati N, Silva M. The matter of lung: quantification of vascular substance in asthma. Am J Respir Crit Care Med. 2018 Jun 8. doi: 10.1164/rccm.201804-0804ED.
  51. Silva M, Pastorino U, Sverzellati N. Prospective randomised controlled trial: fixed 1-year screening interval group versus a tailored intervals group. Thorax. 2018 eLetter: http://thorax.bmj.com/content/early/2018/03/29/thoraxjnl-2017-211107.responses#prospective-randomised-controlled-trial-fixed-1-year-screening-interval-group-versus-a-tailored-intervals-group
    Not indexed in PubMed.
  52. Silva M, Milanese G, Sverzellati N. Interstitial Lung Abnormalities: Definition of Prognostically Relevant Radiological Findings. Curr Opin Pulm Med. 2018 Sep;24(5):432-439. 
    doi: 10.1097/MCP.0000000000000497 
  53. Silva M, Prokop M, Jacobs C, Capretti G, Sverzellati N, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Galeone C, Marchianò A, Pastorino U. Long-term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment. J Thorac Oncol. 2018 Oct;13(10):1454-1463. 
    doi: 10.1016/j.jtho.2018.06.013.
  54. Facchinetti F, Gnetti L, Balestra V, Silva M, Silini EM, Ventura L, Bordi P, Tiseo M. Sarcoid-like reaction mimicking disease progression in an ALK-positive NSCLC patient receiving lorlatinib. Invest New Drugs 2019. 37(2):360-363 
    doi: 10.1007/s10637-018-0652-3.
  55. Walsh SLF, Calandriello L, Silva M, Sverzellati N. A Deep Learning Algorithm for Classifying Fibrotic Lung Disease on High-Resolution Computed Tomography. Lancet Respir Med. 2018 Nov;6(11):837-845. 
    doi: 10.1016/S2213-2600(18)30286-8
  56. Nair A, Bartlett EC, Walsh SLF, Wells AU, Navani N, Hardavella G, Bhalla S, Calandriello L, Devaraj A, Goo JM, Klein JS, MacMahon H, Schaefer-Prokop C, Seo JB, Sverzellati N, Desai SR; Lung Nodule Evaluation Group (Collaborators included Silva M). Variable radiologic lung nodule evaluation leads to divergent management recommendations. European Respiratory Journal 2018. 52(6):1-12  
    doi: 10.1183/13993003.01359-2018
  57. Milanese G, Silva M, Bruno L, Goldoni M, Benedetti G, Rossi E, Ferrari C, La Grutta L, Maffei E, Toia P, Bonadonna RC, Sverzellati N, Cademartiri F. Quantification of Epicardial Fat with cardiac CT and Association with Cardiovascular Risk Factors in Symptomatic Patients: from the ALTER-BIO (Alternative Cardiovascular Bio-Imaging Markers) Registry. Diagn Interv Radiol 2019; 25: 35-41. 
    doi: 10.5152/dir.2018.18037
  58. Papapietro VR, Milanese G, Borghesi A, Sverzellati N, Silva M. Look Around Your Target: a New Approach to Early Diagnosis of Lung Cancer. Ann Transl Med 2018;6(Suppl 1):S77. 
    doi: 10.21037/atm.2018.10.56
  59. Borghesi A, Michelini S, Nocivelli G, Silva M, Scrimieri A, Maroldi R, Farina D. Solid indeterminate pulmonary nodules ≤ 250 mm³: application of the updated Fleischner Society guidelines in clinical practice. Radiology Research and Practice 2019, Article ID 7218258 
    doi: 10.1155/2019/7218258
  60. Ariani A, Silva M, Bravi E, Parisi S, Saracco M, De Gennaro F, Caimmi C, Girelli F, De Santis M, Volpe A, Lumetti F, Hax V, Bredemeier M, Alfieri V, Santilli D, Bodini FC, Mozzani F, Lucchini G, Seletti V, Bacchini E, Arrigoni E, Chakr R, Giuggioli D, Idolazzi L, Bertorelli G, Imberti D, Michieletti E, Paolazzi G, Fusaro E, Chetta A, Scirè CA, Sverzellati N. Overall mortality in Combined Pulmonary Fibrosis and Emphysema related to Systemic Sclerosis. RMD Open 2019;5:e000820. 
    doi: 10.1136/rmdopen-2018-000820
  61. Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, A Marchianò. Prolonged Lung Cancer Screening Reduced 10-year Mortality in the MILD Trial: New Confirmation of Lung Cancer Screening Efficacy. Annals of Oncology (Published: 01 April 2019) 
    doi: 10.1093/annonc/mdz117 
  62. Ledda RE, Milanese G, Gnetti L, Borghesi A, Sverzellati N, Silva M. Spread through air spaces in lung adenocarcinoma: is radiology reliable yet? J Thorac Dis. 2019 Mar;11(Suppl 3):S256-S261. 
    doi: 10.21037/jtd.2019.01.96
  63. Milanese G, Silva M, Frauenfelder T, Eberhard M, Sabia F, Martini C, Marchianò A, Prokop M, Sverzellati N, Pastorino U. Comparison of Ultra-low Dose Chest CT Scanning Protocols for the Detection of Pulmonary Nodules: a Phantom Study. Tumori. 2019 May 1:300891619847271. 
    doi: 10.1177/0300891619847271
  64. Pastorino U, Sverzellati N, Sestini S, Silva M, Sabia F, Boeri M, Cantarutti A, Sozzi G, Corrao G, Marchianò A. Ten-year Results of the MILD Trial Demonstrate the Safety and Efficacy of Biennial Lung Cancer Screening. Eur J Cancer. 2019 Sep;118:142-148. 
    doi: 10.1016/j.ejca.2019.06.009
  65. Ravanelli M, Agazzi GM, Milanese G, Roca E, Silva M, Tiseo M, Rondi P, Baggi A, Ganeshan B, Muri M, Panni S, Botti C, Sverzellati N, Maroldi R, Berruti A, Farina D. Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: a multicentre retrospective study. Eur J Radiol. 2019 Sep;118:251-256. 
    doi: 10.1016/j.ejrad.2019.07.019
  66. Silva M, Milanese G, Pastorino U, Sverzellati N. Lung cancer screening: tell me more about post-test risk. J Thorac Dis 2019;11(9):3681-3688. 
    doi: 10.21037/jtd.2019.09.28
  67. Heidinger BH, Silva M, De Margerie-Mellon C, VanderLaan P, Bankier AA. The Natural Course of Incidentally Detected, Small, Subsolid Lung Nodules – Is Follow-Up Needed Beyond Current Guideline Recommendations? Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S412-S417. 
    doi: 10.21037/tlcr.2019.11.05
  68. Silva M, Milanese G, Cobelli R, Manna C, Rasciti E, Poggesi S, Sverzellati N. CT Angiography for Pulmonary Embolism in the Emergency Department: Optimized Protocol by 20 ml of High-Concentration Contrast Medium. La radiologia medica, 125(2), 137-144. 
    doi: 10.1007/s11547-019-01098-6
  69. Guisado-Vasco P, Silva M, Duarte MA, Sambataro G, Bertolazzi C, Pavone M, Martín-Garrido I, Martín-Segarra O, Luque-Pinilla JM, Santilli D, Sambataro D, Torrisi SE, Vancheri A, Gutiérrez-México M, Mejia M, Palmucci S, Mozzani F, Rojas-Serrano J, Vancheri C, Sverzellati N Ariani A. Quantitative assessment of interstitial lung disease in Sjögren’s syndrome. Plos ONE Volume 14, Issue 11, 2019, Article number e0224772. 
    doi: 10.1371/journal.pone.0224772
  70. Sverzellati N, Silva M, Seletti V, Galeone C, Palmucci S, Piciucchi S, Vancheri C, Poletti V, Tomassetti S, Karwoski R, Bartholmai BJ. Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity. Eur Radiol. 2020. Epub 2020 Jan 31. 
    doi: 10.1007/s00330-019-06619-5
  71. Kauczor HU, Baird AM, Blum TG, Bonomo L, Bostantzoglou C, Burghuber O, Čepická B, Comanescu A, Couraud S, Devaraj A, Jespersen V, Morozov S, Agmon IN, Peled N, Powell P, Prosch H, Ravara S, Rawlinson J, Revel MP, Silva M, Snoeckx A, van Ginneken B, van Meerbeeck JP, Vardavas C, von Stackelberg O, Gaga M, on behalf of the European Society of Radiology (ESR) and the European Respiratory Society (ERS). ESR-ERS joint position paper on Lung Cancer Screening. Eur Respir J. 2020 Feb;55(2). Print 2020 Feb. PubMed PMID: 32051182.
    doi: 10.1183/13993003.00506-2019
  72. Kauczor HU, Baird AM, Blum TG, Bonomo L, Bostantzoglou C, Burghuber O, Čepická B, Comanescu A, Couraud S, Devaraj A, Jespersen V, Morozov S, Agmon IN, Peled N, Powell P, Prosch H, Ravara S, Rawlinson J, Revel MP, Silva M, Snoeckx A, van Ginneken B, van Meerbeeck JP, Vardavas C, von Stackelberg O, Gaga M, on behalf of the European Society of Radiology (ESR) and the European Respiratory Society (ERS). ESR-ERS joint position paper on Lung Cancer Screening. Eur Radiol. 2020 Feb 12; . [Epub ahead of print] PubMed PMID: 32052170.
    doi: 10.1007/s00330-020-06727-7
  73. Sverzellati N, Milanese G, Milone F, Balbi M, Ledda RE, Silva M. Integrated Radiologic Algorithm for COVID-19 Pandemic. J Thorac Imaging. 2020 Jul;35(4):228-233. 
    doi: 10.1097/RTI.0000000000000516.
  74. Milanese G, Silva M, Ledda R, Goldoni M, Nayak SM, Bruno L, Rossi E, Maffei E, Cademartiri F, Sverzellati N. Validity of Epicardial Fat Volume as Biomarker of Coronary Artery Disease in Symptomatic Individuals: Results from the ALTER-BIO Registry. International Journal of Cardiology. Available online 13 April 2020. 
    doi: 10.1016/j.ijcard.2020.04.031
  75. Colombi D, Bodini FC, Petrini M, Maffi G, Morelli N, Milanese G, Silva M, Sverzellati N, Michieletti E. Visual and Software-based Quantification of Well Aerated Lung Obtained by Chest CT for Predictors in COVID-19 Interstitial Pneumonia. Radiology. 2020 Apr 17:201433. 
    doi: 10.1148/radiol.2020201433
  76. Revel MP, Parkar A, Prosch H, Silva M, Sverzellati N, Gleeso F, Brady AP; European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). COVID-19 patients and the Radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur Radiol. 2020 Sep;30(9):4903-4909.
    doi: 10.1007/s00330-020-06865-y
  77. Mazzaschi G, Milanese G, Pagano P, Madeddu D, Falco A, Trentini F, lorusso B, Gnetti L, Lagrasta C, Minari R, Ampollini L, Silva M, Sverzellati M, Tiseo M, Roti G. 
    Integrated CT Imaging and Tissue Immune Features Disclose a Radio-Immune Signature with High Prognostic Impact on Surgically Resected NSCLC. Lung Cancer. 2020 Jun;144:30-39. 
    doi: 10.1016/j.lungcan.2020.04.006
  78. Mazzaschi G, Milanese G, Pagano P, Madeddu D, Gnetti L, Trentini F, Falco A, Frati C, Lorusso B, Lagrasta C, Minari R, Ampollini L, Silva M, Sverzellati N, Quaini F, Roti G, Tiseo M. Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. Data in Brief Volume 31, August 2020, 105781
    doi: 10.1016/j.dib.2020.105781
  79. Scarlattei M, Baldari G, Silva M, Bola S, Sammartano A, Migliari S, Graziani T, Cidda C, Sverzellati N, Ruffini L. Unknown SARS-CoV-2 pneumonia detected by PET/CT in cancer patients. Tumori Journal publishd online 22 June 2020
    doi: 10.1177/0300891620935983
  80. Ruscitti F, Ravanetti F, Bertani V, Ragionieri L, Mecozzi L, Sverzellati N, Silva M, Ruffini L, Menozzi V, Civelli M, Villetti G, Stellari FF. Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography. Front Pharmacol. 2020 Jul 21;11:1117. 
    doi: 10.3389/fphar.2020.01117.
  81. Carnevale A, Silva M, Maietti E, Milanese G, Saracco M, Parisi S, Bravi E, De Gennaro F, Arrigoni E, Bodini FC, Fusaro E, Scirè CA, Sverzellati N, Ariani A. Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests. Clin Rheumatol. 2020 Sep 3. Online ahead of print.
    doi: 10.1007/s10067-020-05375-y
  82. Silva M, Milanese G, Kauczor HU, Revel MP, Sverzellati N. Milestones towards lung cancer screening implementation. Clin Radiol. 2020 Aug 27:S0009-9260(20)30316-0. 
    doi: 10.1016/j.crad.2020.07.028
  83. Silva M, Milanese G, Sestini S, Sabia F, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop CM, Marchianò A, Sverzellati N, Pastorino U. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval. Eur Radiol Epub 2020 Sep 30.
    doi: 10.1007/s00330-020-07275-w
  84. Balbi M, Caroli A, Corsi A, Milanese G, Surace A, Di Marco F, Novelli L, Silva M, Lorini F, Cosentini R, Sverzellati N, Bonaffini PA, Sironi S.Chest X-ray for predicting mortality and the need for ventilatory support in COVID-19 patients presenting to the emergency department. Eur Radiol Epub 2020 Oct 8.
    doi: 10.1007/s00330-020-07270-1
  85. Colombi D, Petrini M, Maffi G, Villani GD, Bodini FC, Morelli N, Milanese G, Silva M, Sverzellati N, Michieletti E. Comparison of admission chest computed tomography and lung ultrasound performance for diagnosis of COVID-19 pneumonia in populations with different disease prevalence. Eur J o Radiol Epub 2020 Oct 8.
    doi: 10.1016/j.ejrad.2020.109344
  86. Balbi M, Ristani A, Milanese G, Silva M, Ledda RE, Milone F, Sartorio C, Tringali G, Sverzellati N. The role of the radiologist in diagnosing the covid-19 infection. Parma experiences. Acta Bio-Medica De L'ateneo Parmense - ISSN:0392-4203 vol. 91 (2)
    doi: 10.23750/abm.v91i2.9564
  87. Colombi D, Bodini FC, Morelli N, Silva M, Milanese G, Cavanna L, Michieletti E. COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients. J Infect Chemother. 2020 Sep 10;S1341-321X(20)30328-7
    doi: 10.1016/j.jiac.2020.09.008
  88. Mecozzi L, Mambrini M, Ruscitti F, Ferrini E, Ciccimarra R, Ravanetti F, Sverzellati N, Silva M, Ruffini L, Belenkov S, Civelli M, Villetti G, Stellari FF. In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach. Sci Rep. 2020 Oct 30;10(1):18735. 
    doi: 10.1038/s41598-020-71293-3.
  89. Colombi D, Villani GD, Maffi G, Risoli C, Bodini FC, Petrini M, Morelli N, Anselmi P, Milanese G, Silva M, Sverzellati N, Michieletti E. Qualitative and quantitative chest CT parameters as predictors of specific mortality in COVID-19 patients. Emerg Radiol. 2020 Dec;27(6):701-710. 
    doi: 10.1007/s10140-020-01867-1
  90. Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Interstitial lung disease in Sjögren’s syndrome: a clinical review. Clin Exp Rheumatol. Jul-Aug 2020;38 Suppl 126(4):291-300 
    PMID: 33095142
  91. Ariani, Sverzellati N, Milanese G, Becciolini A, Silva M. Using quantitative computed tomography to predict mortality in patients with interstitial lung disease related to systemic sclerosis: implications for personalized medicine. Expert Review of Precision Medicine and Drug Development 2021
    doi: 10.1080/23808993.2021.1858053
  92. Ledda RE, Milanese G, Cademartiri F, Maffei E, Benedetti G, Goldoni M, Silva M, Sverzellati N. Association of hepatic steatosis with epicardial fat volume and coronary artery disease in symptomatic patients. Radiol Med. 2021 Jan 3. 
    doi: 10.1007/s11547-020-01321-9.
  93. Bartlett E, Silva M, Callister M, Devaraj A. False negative results in lung cancer screening - Evidence and Controversies. J Thorac Oncol. 2021 Feb 2:S1556-0864(21)01652-X. 
    doi: 10.1016/j.jtho.2021.01.1607
  94. Ugolotti MC, Pedrazzini M,  Silini EM, Missale G, Silva M, Franzini C, Palmieri G, Costi R, Montali F, Gnappi E, Terroni L, Colizzi E, Meschi M, Facchinetti F. Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient. J Med Virol 2021 Jan 17.
    doi: 10.1002/jmv.26803
  95. Sverzellati N, Ryerson C, Milanese G, Renzoni E, Volpi A, Spagnolo P, Bonella F, Comelli I, Manna C, Ciuni A, Sartorio C, Tringali G, Silva M, Michieletti E, Colombi D, Wells A. Chest radiography or computed tomography for suspected COVID-19 pneumonia? A comparative study in a simulated triage setting. Eur Respir J. 2021 Feb 11:2004188. 
    doi: 10.1183/13993003.04188-2020
  96. Silva M, Ledda RE, Schiebler M, Balbi M, Milone F, Sverzellati N. Frequency of Typical and Ancillary Chest CT Findings in COVID-19 Infection. Br J Radiol. 2021 Feb 1;94(1118):20200716. 
    doi: 10.1259/bjr.20200716
  97. Schreuder A, Jacobs C, Lessmann N, Broeders MJ, Silva M, Išgum I, de Jong PA, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B. Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening. Eur Respir J. 2021 Feb 11:2003386. 
    doi: 10.1183/13993003.03386-2020
  98. Caminiti C, Maglietta G, Meschi T, Ticinesi A, Silva M, Sverzellati N. Effects of the Covid-19 epidemic on hospital admissions for Non-Communicable Diseases in a large Italian University-Hospital: a descriptive case-series study. J Clin Med 2021 Feb 21;10(4):880
    doi: 10.3390/jcm10040880
  99. Ventura L, Carbognani P, Gnetti L, Rossi M, Tiseo M, Silini EM, Sverzellati N, Silva M, Succi M, Braggio C, Cattadori S, Bocchialini G, Balestra V, Rusca M, Ampollini L. Multiple primary malignancies involving lung cancer: a single-center experience. Tumori. 2021 Jun;107(3):196-203
    doi: 10.1177/0300891620933678
  100. Avila R, Fain SB, Hatt C, Armato S, Mulshine JL, Gierada D, Silva M, Lynch DA, Hoffman EA, Ranallo F, Mayo JR, Yankelevitz D,  San Jose Estepar R, Subramaniam R, Henschke C, Guimaraes A, Sullivan D.
    QIBA Guidance: Computed Tomography Imaging for COVID-19 Quantitative Imaging Applications. Clin Imaging 2021 Feb 25;77:151-157. Online ahead of print.
    doi: 10.1016/j.clinimag.2021.02.017
  101. Mazzaschi G, Quaini F, Milanese G, Madeddu D, Bocchialini G, Ampollini L, Gnetti L, Lagrasta C, Silva M, Roti G, Sverzellati N, Tiseo M. Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC. Annals of Oncology30 (Supplement 2): ii1–ii6, 2019.
    doi: 10.1093/annonc/mdz072
  102. Trentini F, Mazzaschi G, Milanese G, Madeddu D, Gnetti L, Frati C, Lorusso B, Lagrasta C, Minari R, Ampollini L, Ledda RE, Pavone C, Silva M, Sverzellati N, Quaini F, Roti G, Tiseo M. A Validation of a Radiomic Approach to Decipher NSCLC Immune Microenvironment in Surgically Resected Patients. Tumori. 2021 Mar 17:3008916211000808. Online ahead of print.
    doi: 10.1177/03008916211000808
  103. Tringali G, Milanese G, Ledda RE, Pastorino U, Sverzellati N, Silva M. Lung Cancer Screening: evidence, harms and opportunities for implementation. Rofo. 2021 Mar 26. Online ahead of print.
    doi: 10.1055/a-1382-8648.
  104. Ventura L, Gnetti L, Rossi M, Tiseo M, Silini EM, Sverzellati N, Silva M, Milanese G, Minari R, Cattadori S, Bocchialini G, Ampollini L, Carbognani P, Mozzoni P. The role of miRNA-221 and miRNA-126 in patients with Benign Metastasizing Leiomyoma of the lung: an overview with new interesting scenarios. Mol Biol Rep. 2021 Apr 15. Online ahead of print. 
    doi: 10.1007/s11033-021-06322-z
  105. Ma Q, Chen Y, Xiao F, Hao Y, Song Z, Zhang J, Okuda K, Um SW, Silva M, Shimada Y, Si C, Liang C. A Signature of Estimate-Stromal-Immune Score-Based Genes Associated with The Prognosis of Lung Adenocarcinoma. Transl Lung Cancer Res. 2021 Mar;10(3):1484-1500.
     doi: 10.21037/tlcr-21-223 
  106. Snoeckx A, Franck C, Silva M, Revel MP. Radiologist’s role in lung cancer screening. The radiologist’s role in lung cancer screening. Transl Lung Cancer Res. 2021 May;10(5):2356-2367.
    doi: 10.21037/tlcr-20-924
  107. Silva M, Milanese G, Ledda RE, Pastorino U, Sverzellati N. Screen-detected solid nodules: from nodule management to structured reporting. Transl Lung Cancer Res. 2021 May;10(5):2335-2346.
    doi: 10.21037/tlcr-20-296
  108. Silva M, Maddalo M, Leoni E, Giuliotti S, Milanese G, Ghetti C, Biasini E, Missale G, Sverzellati N. Integrated prognostication of intrahepatic cholangiocarcinoma by contrast enhanced computed tomography: the adjunct yield of radiomics. Abdom Radiol (NY). 2021 Oct;46(10):4689-4700. Epub 2021 Jun 24.
    doi: 10.1007/s00261-021-03183-9
  109. Sambataro D, Colaci M, Battisti S, Orlandi M, Cavagna L, Fazio G, Sverzellati N, Silva M, Malatino L, Ariani A. Feasibility, face and content validity of Quantitative Computed Tomography in Interstitial Lung Disease related to Connective Tissue Diseases. J Basic Clin Physiol Pharmacol. 2021 Jul 19
    doi: 10.1515/jbcpp-2021-0110
  110. Casartelli C, Perrone F, Balbi M, Alfieri V, Milanese G, Buti S, Silva M, Sverzellati N, Bersanelli M. Review on radiological evolution of COVID-19 pneumonia using computed tomography. World J Radiol 2021 September 28; 13(9): 294-306
    doi: 10.4329/wjr.v13.i9.294
  111. Buti S, Perrone F, Zielli T, Mazzaschi G, Casartelli C, Leonetti A, Milanese G, Silva M, Ledda RE, Musolino A, Pucci F, Bersanelli M, Tiseo M. Clinical Impact Of COVID-19 Outbreak On Cancer Patients: A Retrospective Study. Clinical Medicine Insights: Oncology 2021 Volume 15: 1–8
    doi: 10.1177/11795549211043427

Accepted Articles In Press

  1. Precision Cancer Medicine: Menis J, Silva M, Vavalà T, Evangelista L, Hasan B, Guarneri V, Conte PF, Caramella C. From RECIST to immune-RECIST: how to assess disease response to checkpoint inhibitors.
  2. European Respiratory Journal : Schreuder A, Jacobs C, Lessmann N, Broeders MJM, Silva M, Išgum I, de Jong PA, van den Heuvel MM, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B. Scan-based competing death risk model for reevaluating lung cancer computed tomography screening eligibility.
  3. European Radiology: Martini K, Larici AR, Revel MP, Ghaye B, Sverzellati N, Parkar AP, Snoeckx A, Screaton N, Biederer J, Prosch H, Silva M, Gleeson F, Brady A, Frauenfelder T. COVID-19 pneumonia imaging follow-up: when and how? A proposition from ESTI and ESR.
    doi: 10.1007/s00330-021-08317-7
  4. Radiology – Artificial Intelligence: Jacobs C, Setio AAA, Scholten ET, Gerke PK, Bhattacharya H, Mohamed Hoesein F, Brink M, Ranschaert E, de Jong P, Silva M, Geurts B, Chung K, Schalekamp S, Meersschaert J, Devaraj A, Pinsky P, Lam S, van Ginneken B, Farahani K. 
    Lung Cancer Detection in Screening CT Scans: Results from a Public Machine Learning Competition and an Observer Study.

Submitted Articles

  1. European Radiology: Nemec U, Nemec SF, Silva M, Heidinger BH, Dufresne V, Bankier AA. 
    CT Quantification of the Airways in Young and Healthy Individuals.
  2. Annals of Oncology: Pastorino U, Boeri M, Sestini S, Sabia F, Milanese G, Silva M, Suatoni P, Verri C, Cantarutti A, Sverzellati N, Corrao G, Marchianò A, Sozzi G. 
    Blood micro RNA and LDCT predict individual risk and reduce unnecessary examinations in lung cancer screening: results of BioMILD trial
  3. British Journal of Radiology: Silva M, Milanese G, Ledda RE, Pastorino U, Sverzellati N. European lung cancer screening: from trial to practice.
  4. Insightsinto Imaging: Ledda RE, Milanese G, Milone F, Balbi M, Silva M, Sverzellati N. Interstitial lung abnormalities: new insights between theory and clinical practice
  5. British Journal of Radiology: Milanese G, Mazzaschi G, Ledda RE, Balbi M, Lamorte S, Colombi C, Tiseo M, Silva M, Sverzellati N. Immunotherapy For Lung Cancer and Imaging Appearances.
  6. La Radiologia Medica: Ledda RE*, Silva M*, McMichael N, Sartorio C, Branchi C, Milanese G, Nayak SM, Sverzellati N. The diagnostic value of grey-scale inversion technique in chest radiography.
  7. Lung cancer: Aleshina OO, Lancaster HL, Zheng S, Chernina VY, Heuvelmans MA, Silva M, Dorrius MD, Morozov SP, Gombolevsky VA, Oudkerk M. Volumetry versus linear diameter lung nodule measurement; an ultra-low-dose CT Lung Cancer Screening Study.
  8. Respiratory research: Grandi A, Ferrini E, Ciccimarra R, Mambrini M, Mecozzi L, Leo L, Silva M, Sverzellati N, Donofrio G, Ruffini L, Villetti G, Stellari FF. Multimodality approach to characterizing the distinctive hallmarks of lung fibrosis: a mouse model with bleomycin and indocyanine green.
  9. Lung Cancer: Lancaster HL, ZhengS, Aleshina OO, Yu D, Chernina VY, Heuvelmans MA, Dorrius MD, Gratama JW, Morozov SP, Gombolevsky VA, Silva M, Yi J, Oudkerk M. Outstanding negative prediction performance of solid pulmonary nodule volume AI for ultra-LDCT baseline lung cancer screening risk stratification.
  10. CHEST: Stephen H, ; Mackintosh J, Jo H, Walsh S, Calandriello L, Glaspole I, Corte TJ, Silva M, Chapman S, Ellis S, Goh N, Grainge C, Hopkins P, Keir G, Moodley Y, Reynolds P, Walters H, Lynch D. Quantitative CT Predicts Patient Outcomes in IPF: Analysis from the Australian IPF Registry
  11. La Radiologia Medica: Silva M, Picozzi G, Sverzellati N, Anglesio S, Bartolucci M, Cavigli E, Deliperi A, Falchini M, Falaschi F, Ghio D, Gollini P, Larici AR, Marchianò AV, Palmucci S, Preda L,  Romei C, Tessa C, Rampinelli C, Mascalchi M. Low-dose CT for Lung Cancer Screening: Italian Position Paper.
     

Congresses And Courses
 Abstract Of Scientific Poster Presentation

1.     RSNA 2010 (Congress of the Radiological Society of North America) - Chicago, Illinois
De Filippo M, Silva M, Johnson KM, Bertone C, Zompatori M, Rossi C. Accuracy of Multiplanar Reformatted CT Imaging in the Quantification of Glenoid Bone Loss Following Shoulder Dislocation.

2.     ECR 2011 (Congress of the European Society of Radiology) - Vienna, Austria
Martini C, Maffei E, Sverzellati N, Silva M, Arcadi T, Seitun T, Clemente A, Lario C, Cademartiri F; Parma/IT. #3826 - C-1169 Coronary calcium score assessed on unenhanced low-dose chest CT: feasibility study. Type: Scientific Paper.

3.     ESTI meeting 2012 (Meeting of the European Society of Thoracic Imaging) - London, United Kingdom
Silva M, Colombi D, Buttarelli L, Ranalli A, Seletti V, Mereu M, Rossi C, Sverzellati N. Extension of Pulmonary Fibrosing Diseases: a Comparison of Quantification Scoring Systems.

4.     Quantitative CT Symposium at STR Meeting 2014, March 15 (Society of Thoracic Radiology) - San Antonio, Texas
Silva M, Nemec S, Dufresne V, Molinari F, Bankier AA. Lobar Contribution to Lung Volume in Healthy Subjects: Quantitative Assessment by CT.

5.     ATS Meeting 2014, May 16-21 (Meeting of the American Thoracic Society) – San Diego, California
DuBrock HM, Bankier AA, Silva M, Litmanovich DE, Curry MP, Washko GR. Pulmonary vessel cross-sectional area before and after liver transplant.

6.     100th Meeting of the Radiological Society of North America (RSNA), November 30 – December 5, 2014 – Chicago, IL
Silva M, Nemec SF, Heidinger BH, Occhipinti M, Dufresne V, Molinari F, Bankier AA. Lung Volume and Heterogeneity: CT Quantification of Lobar Contribution.

7.     16th World Congress on Lung Cancer , September 6-9, 2015 (International Association for Surgery of Lung Cancer – IASLC) – Denver, Colorado
Silva M, Galeone C, Sverzellati N, Marchianò A, Calareso G, Sestini S, La Vecchia C, Sozzi G, Pelosi G, Pastorino U. Small Cell Lung Cancer in Lung Cancer Screening: Frequency and Outcome.

8.     European Respiratory Society (ERS) International Congress 2015, September 26-30 – Amsterdam, The Netherlands. Alfieri V, Milanese G, Panagiota T, Aiello M, Silva M, Sverzellati N, Marangio E, Chetta A. COPD Phenotypes by High Resolution Computed Tomography (HRCT) and Ventilatory Response to Exercise

  1. ECR 2016, March 2-6 (European Congress of Radiology) - Vienna, Austria
    Milanese G, Silva M, Borghesi A, Bezzi M, Bonifazi M, Novali M, Sverzellati N. Treatment of emphysema: procedure planning and follow-up by HRCT
  2. Joint Meeting of European Society of Thoracic Imaging (ESTI) and European Society of Cardiovascular Radiology (ESCR) – Geneva 2018, Switzerland
    Casilli E, Silva M, Milanese G, Sverzellati N. Quantitative CT imaging of the lung: Current applications and future perspectives in diagnostics of nodule and diffuse lung disease
  3. European Congress of Rheumatology EULAR 2018 – Amsterdam, The Netherlands.
    Bertolazzi C, Silva M, Rojas-Serrano J, Carnevale A, Sverzellati N, Gutierrez M, Alfaro-Rodriguez A, Ariani A. Quantitative CT Indexes in the Evaluation of Interstitial Lung Disease Related to Rheumatoid Arthritis
  4. National Research Program 78 “Covid-19” 1st Programme Conference – April 28-29, 2021 – Online from Bern, Switzerland. 
    AI-multi-omics-based Prognostic Stratification of COVID-19 Patients in Acute and Chronic State.
    PIs: Pöllinger A, Reyes M, Duncan J, Sverzellati N.
    Project Partners: Cortopassi IO, Hautz W, Dela Cruz C, Caminiti C.
    Team Members: Garcia Henao J, He G, Silva M, Staib L, You C, Yang J, Gange C, Bajercius H, Depotter A, Barroso C, Schröder E, Pahud de Mortanges A.
  1. European Society of Medical Oncology (ESMO) 2021 Conference, September 16-21 – Online
    Mazzaschi G, Scandino R, Milanese G, Pavone C, Balbi M, Moron Dalla Tor L, Silva M, Ledda RE, Minari R, Trentini F, Bordi P, Buti S, Leonetti A, Quaini F, Sverzellati N, Romanel A, Tiseo M. #3456 A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
     

Abstract Of Oral PresentationsYear 2011

ECR 2011, March 6-10 (European Congress of Radiology) - Vienna, Austria

  1. Sverzellati N, Randi G, Calabrò E, Silva M, Kunhigk JM, Marchianò A, Zompatori M, Pastorino U. Relationship between lung cancer and pulmonary emphysema.

Year 2014

Third Systemic Sclerosis World Congress, February 6-8, 2014

  1. Ariani A, Lumetti F, Santilli D, Mozzani F, Silva M, Delsante G, Sverzellati N. Systemic sclerosis interstitial lung disease evaluation: comparison between semiquantitative and quantitative CT assessment.

ECR 2014, March 6-10 (European Congress of Radiology) - Vienna, Austria

  1.  Silva M, Centra F, Colombi D, Rossi C, Sverzellati N, Bankier AA. Ground glass nodules: CT-epidemiological analysis of growth patterns.
  2. Silva M, Kienzl D, Mueller-Mang C, Jaskch P, Klepetko W, Bankier AA. Quantitative CT in the follow up of functionally stable lung transplant recipients.
  3. Silva M, Centra F, Colombi D, Ampollini L, Carbognani P, Rossi C, Sverzellati N. Ground glass nodules evolution according with an history of tumour.
  4. Colombi D, Diciotti S, Manna C, Montermini I, Fontana E, Rossi C, Silva M, Tiseo M, Sverzellati N. Three-dimensional analysis of advanced stage NSCLC: prognostic significance of volumetric measurements

STR Meeting 2014, March 16-18 (Society of Thoracic Radiology) - San Antonio, Texas

  1. Silva M, Centra F, Colombi D, Rossi C, Sverzellati N, Bankier AA. Ground glass nodules: CT-epidemiological analysis of growth patterns.
  2. Silva M, Kienzl D, Mueller-Mang C, Jaskch P, Klepetko W, Bankier AA. Quantitative CT in the follow up of functionally stable lung transplant recipients.

Congresso Nazionale SIRM 2014, May 22-25 (Societa Italiana di Radiologia Medica) - Firenze, Italy

  1. Silva M, Centra F, Colombi D, Rossi C, Sverzellati N, Bankier AA. Noduli subsolidi: analisi radiologico epidemiologica dei pattern di evoluzione.
  2. Silva M, Kienzl D, Mueller-Mang C, Jaskch P, Klepetko W, Bankier AA. Analisi quantitative della tomografia computerizzata nel follow up del trapianto polmonare bilaterale in pazienti clnicamente stabili.

100th Meeting of the Radiological Society of North America (RSNA), November 30 – December 5, 2014 – Chicago, IL

  1. Silva M, Kienzl D, Mueller-Mang C, Jaskch P, Klepetko W, Bankier AA. Longitudinal Assessment of Tissue Loss and Air Trapping in Functionally Stable Lung Transplant Recipients Using Quantitative CT measurements.

Year 2015

ECR 2015, March 4-8 (European Congress of Radiology) - Vienna, Austria

  1. Silva M, Sverzellati N, Colombi D, La Vecchia C, Galeone C, Marchiano A, Pastorino U. Pleural abnormalities in lung cancer screening trial: prevalence, features, and relation with cancer.

American Thoracic Society 2015 International Conference, May 15-20, 2015 – Denver, CO

  1. Colombi D, Sverzellati N, Silva M, Kauczor HU, Ehlers-Tenenbaum S, Baroke E, Herth FJ, Heussel CP, Eichinger M, Kreuter M. Spontaneous Pneumomediastinum Is A Predictor Of Mortality In Patients With Idiopathic Pulmonary Fibrosis

Joint Meeting of European Society of Thoracic Imaging (ESTI) and Fleischner Society 2015, June 4-6 – Barcelona, Spain

  1. Silva M, Sverzellati N, Colombi D, La Vecchia C, Galeone C, Marchiano A, Pastorino U. Prevalence and features of pleural abnormalities in lung cancer screening trial: relation with asbestos exposure and risk of lung cancer.

Year 2016

ECR 2016, March 2-6 (European Congress of Radiology) - Vienna, Austria.

  1. Silva M, Sverzellati N, Galeone C, Calareso G, Marchianò A, Sestini S, Sozzi G, Pastorino U. Low­Dose Computed Tomography for Lung Cancer Screening: Comparison of Performance Between Annual and Biennial Screen.

Congresso Nazionale SIRM 2016, September 15-18 (Societa Italiana di Radiologia Medica) - Napoli, Italy

  1. Zambrini E, Silva M, Chiari G, Montermini I, Manna C, Sverzellati N. Valutazione pre-chirurgica dell’invasione mandibolare nelle neoplasie del cavo orale: confronto tra diverse metodiche di imaging e fra diversi livelli di esperienza specialistica
  2. Silva M, Sverzellati N, Marchianò A, Galeone C, Sestini S, Pastorino U. Screening del Tumore Polmonare con Tomografia Computerizzata a Bassa Dose: Confronto di Prestazioni tra Screening Annuale e Biennale

Year 2017

ECR 2017, March 1-5 (European Congress of Radiology) - Vienna, Austria.

  1. Silva M, Capretti G, Sverzellati N, Jacobs J, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Marchianò A, Pastorino U.  Subsolid and Part-Solid Nodules In Lung cancer Screening: Comparison Between Visual and Computer-Aided Detection.

4th World Congress of Thoracic Imaging (WCTI), June 18-21 – Boston (MA), USA

  1. Silva M, Capretti G, Sverzellati N, Jacobs J, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Prokop M, Marchianò A, Pastorino U.  Subsolid and Part-Solid Nodules In Lung cancer Screening: Comparison Between Visual and Computer-Aided Detection.

Year 2018

ECR 2018, February 28 - March 4 (European Congress of Radiology) - Vienna, Austria.

  1. Milanese G, Silva M, Bruno L, Goldoni M, Maffei E, Cademartiri F, Sverzellati N. Epicardial fat volume as a potential imaging biomarker for coronary artery disease in symptomatic patients.
  2. Milanese G, Silva M, Seletti V, Galeone C, Bartholmai BJ, Palmucci S, Piciucchi S, Karwoski RA, Sverzellati N. Follow-Up of Idiopathic Pulmonary Fibrosis: Computed Tomography vs Functional Metrics.
  3. Silva M, Jacobs C, Galeone C, Capretti G, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Prokop M, Marchianò A, Pastorino U, Sverzellati N. Active surveillance of subsoil nodules detected by screening: safe strategy to reduce overtreatment. 

Joint Meeting of European Society of Thoracic Imaging (ESTI) and European Society of Cardiovascular Radiology (ESCR), May 24-26 - Geneva, Switzerland.

  1. Silva M, Milanese G, Seletti V, Galeone C, Bartholmai BJ, Palmucci S, Piciucchi S, Karwoski RA, Sverzellati N. Information from Computed Tomography follow-up in Idiopathic Pulmonary Fibrosis: iPFBC Multicenter Pooled Comparison with clinical and functional metrics

European Society of Medical Oncology (ESMO) 2018 Conference, October 19-23 – Munich, Germany

  1. Cavalieri S, De Cecco L, Calareso G, Silva M, Gazzani SE, Bologna M, Nauta I, Wesseling F, Lopez Perez L, Shefi R, Tountopoulos V, Fico G, Scheckenbach K, Brakenhoff RH, Hoebers F, Canevari S, Poli T, Licitra L, Mainardi L, BD2Decide Consortium. Genomics features (GF) and integration with MRI radiomics features (RF) to develop a prognostic model in oral cavity squamous cell carcinoma (OSCC)

Year 2019

ECR 2019, February 28 - March 3 (European Congress of Radiology) - Vienna, Austria.

  1. Pastorino U, Silva M, Sabia F, Sestini S, Boeri M, Sozzi G, Sverzellati N, Marchianò A. Low-dose computed tomography (LDCT) screening reduces overall and lung cancer specific mortality beyond 5 years.
  2. Silva M, Sabia F, Milanese G, Sestini S, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop CM, Sverzellati N, Marchianò A, Pastorino U. Lung cancer risk after baseline round of screening: only 20% of NLST eligibles require annual round. [Selected for Clinical Trials in Radiology (CTiR) scientific session, discussant Prof. Kauczor H.U.; invited abstract for the press conference within the CTiR]
  3. Colombi D, Chiesa S, Bodini F, Morelli N, Silva M, Sverzellati N, Franco C, Michieletti E. Difference between measurement of T size at Computed Tomography and at resected specimen: is it relevant for NSCLC stage?
  4. Milanese G, Cobelli R, Manna C, Silva M, Rasciti E, Poggesi S, Sverzellati N. CT angiography for pulmonary embolism in the emergency department: diagnostic accuracy of 20ml high-concentration contrast medium.

Joint Meeting of European Society of Thoracic Imaging (ESTI) and Fleischner Society 2019, May 9-11 – Paris, France

  1. Silva M, Sabia F, Sestini S, Boeri M, Sozzi G, Marchianò A, Sverzellati N, Pastorino U. Low-dose computed tomography (LDCT) screening reduces lung cancer mortality beyond 5 years.
  2. Silva M, Milanese G, Sabia F, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop CM, Marchianò A, Sverzellati N, Pastorino U. Lung cancer risk after baseline round of screening: only 20% of NLST eligibles require annual round.
  3. Milanese G, Silva M, Frauenfelder T, Eberhard M, Sverzellati N, Pastorino U. Comparison of Ultra-Low Dose Chest CT Scanning Protocols for the Detection  Pulmonary Nodules According to LungRADS Categories: a Phantom Study. 

105th Meeting of the Radiological Society of North America (RSNA), December 1 – 6, 2019 – Chicago, IL

  1. Silva M, Milanese G, Sabia F, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop C, Sestini S, Marchianò A, Sverzellati N, Pastorino U. Lung Cancer Screening in NLST Eligibles: Tailoring Annual Low-Dose Computed Tomography by Post-Test Risk Stratification

Year 2021

European Society of Medical Oncology (ESMO) 2021 Conference, September 16-21 – Online

  1. Girard N, Ponce Aix S, Cedres S, Berghmans T, Burgers S, Toffart AC, Popat S, Janssens A, Gervais R, Hochstenbag M, Silva M, Burger IA, Prosch H, Stahel R, Govaerts AS, Pochesci A, Neven A, Peters S. Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: Results from the EORTC-ETOP NIVOTHYM phase II trial.

Congresses/Courses AS FACULTY: Invited SpeakerYear 2011

  1. Congresso Regionale Associazione Italiana Pneumologi Ospedalieri (AIPO) Lombardia: “La HRCT nelle patologie Ostruttive Polmonari: non solo enfisema”. October 07-08, 2011 - Milano (IT).
  2. II Raduno regionale del Gruppo SIRM Emiliano-Romagnolo: “Interstiziopatie Diffuse”. November 18, 2011 - Bologna (IT).

Year 2012        

  1. Simpòsio Brasil-Itàlia, Mòdulo Pneumologia: Avaliação radiológica, Session of Interstitial Lung Diseases. May 9-11, 2012 - Parma (IT).
  2. Integrazione Ospedale-Territorio, “Ipertensione polmonare - Percorso Diagnostico Terapeutico”. September 27, 2012 - Parma (IT)

Year 2014

  1. Corso Avanzato di HRCT. April 9-11 and May 14-16, 2014 - Parma (IT).
  2. HERMES National Summer School 2014 (European Respiratory Society). July 7-10, 2014 - Milan (IT).
  3. 4th International Thoracic Oncology Congress Dresden (ITOCD 4), September 12-14, 2014 - Dresden (DE).
  4. HRCT delle malattie polmonari diffuse. Sezione di Radiologia Toracica, Società Italiana di Radiologia Medica (SIRM). October 10, 2014 - Trento (IT).
  5. TC ad Alta Risoluzione del Torace. Sezione di Radiologia Toracica, Società Italiana di Radiologia Medica (SIRM). November 14, 2014 - Roma (IT).

Year 2015

  1. Thoracic Surgery Part I – European Association of Cardio-Thoracic Surgery (EACTS) : “Screening for Lung Cancer and Sleeve Resections”. April 13-17, 2015 – Windsor (UK)
  2. IV Congresso Nazionale AIMAR - 8th International Conference on Management & Rehabilitation of Chronic Respiratory Failure: “L’ Imaging in Oncologia Polmonare”. May 6-9, 2015 – Pescara (IT)
  3. Joint Meeting European Society of Thoracic Imaging (ESTI) and Fleischner Society.  “Parametric response maps: A new clinical tool for imaging?”. June 4-6, 2015 – Barcelona (ES)
  4. Euroregional Conference on Thoracic Oncology: “Lung Cancer Screening by Spiral CT”. June 12-13, 2015 - Vilnius (LT)
  5. Convegno Nazionale della Sezione di Radiologia Toracica della SIRM; Sessione “Broncopneumopatia Cronica Ostruttiva: Focus sulla Patologia Ostruttiva delle Piccole Vie Aeree” : Diagnostica per Immagini per la “Daily Practice” . September 16-18, 2015 – Parma (IT). 
  6. Corso di Formazione Teorico-Pratico dell’Associazione Italiana Pneumologi Ospedalieri (AIPO) - Tubercolosi: Emergenza Sanitaria Globale. “Aspetti Radiologici della Malattia Tubercolare”. October 8-9, 2015 – Parma (IT).
  7. HRCT delle malattie polmonari diffuse. Sezione di Radiologia Toracica, Società Italiana di Radiologia Medica (SIRM). October 9-10, 2015 - Rovereto (IT).
  8. Thoracic Imaging - European Respiratory Society (ERS) : “Mediastinum” 22-24 October, 2015 – Barcelona (E)  

Year 2016

  1. PneumoTrieste 2016: “Lo screening del tumore polmonare: siamo pronti?”. April 11-13, 2016 – Trieste (IT). 
  2. Congresso della Sezione Regionale AIPO Emilia Romagna, Sessione “Coinvolgimento Polmonare nelle Patologie Reumatologiche”, April 20, 2016 – Modena (IT)
  3. Corso AIPO – V Post Graduate Course “LE PNEUMOPATIE INTERSTIZIALI DIFFUSE | PID |”, April 28-30, 2016 – Gubbio (IT)
  4. 19th WCBIP/WCBE World Congress - Joint Meeting of the World Association for Bronchology and Interventional Pulmonology and the International Bronchoesophagological Society, May 8-11, 2016 – Florence (IT)
  5. “International Symposium on: COPD” organized by the University of Florence, June 23-25, 2016 – Florence (IT)
  6. XVII Congresso Nazionale della Pneumologia, Session “Imaging Toracico”, Lecture: “Sistemi di quantificazione delle malattie infiltrative diffuse” AND Session “Screening del tumore del polmone mediante TC toracico a bassa dose: mito o realtà?”, Lecture “Indicazioni sullo screening”, October 5-7, 2016 – Milan (IT)
  7. Corso di Formazione Teorico-Pratico dell’Associazione Italiana Pneumologi Ospedalieri (AIPO) - Tubercolosi: Emergenza Sanitaria Globale. “Aspetti Radiologici della Malattia Tubercolare”. October 20-21, 2016 – Parma (IT)
  8. IV HERMES National School, Lecture “Lung Imaging”, November 28-Decemeber 1, 2016 – Milan (IT)

Year 2017

  1. Course “Diffuse Lung Diseases: a Multidisciplinary Approach”, Lecture “Nodular pattern on HRCT”, January 20, 2017 – Bologna (IT).
  2. ECR 2017 (European Congress of Radiology) – Session (RC 1204): “Thoracic manifestations of systemic disease”, Lecture: “Systemic sclerosis”, March 1-5 (European Congress of Radiology) - Vienna, Austria.
  3. 6th AIR Meeting Italia, Session “Interactive Workshop on Fibrotic Lung Diseases – Multidisciplinary Clinical Challenge”, March 31-April1, 2017 – Bologna (IT).
  4. Convegno Nazionale della Sezione di Radiologia Toracica della SIRM, Session “Lo screening del tumore polmonare”, Lecture “Linee guida e raccomandazioni internazionali a confronto” – September 14-16, 2017 – Rome (IT). 
  5. Course “Aspetti pratici di gestione dell’immunoterapia nella pratica clinica: fra PDL1, tossicità endocrinologica e pseudo-progressione”, Lecture “Imaging in corso di immunoterapia”, September 18, 2017 – Parma (IT).
  6. Course “Master in Asma Bronchiale”, Lecture “Imaging dell’asma grave e della rinosinusite”, September 29-30, 2017 – Garbagnate Milanese (IT).
  7. Course “Master Class di Radiologia”, Lecture “Il CAD nelle malattie diffuse polmonari”, October 9-10, 2017 – Parma (IT).
  8. Course “Imaging Oncologico Polmonare”, Lecture “Screening”, October 17, 2017 – Bologna (IT) 
  9. Congress “Tosse e dispnea nella pratica clinica”, Lecture “Ruolo dell’imaging nella dispnea”, November 17-18, 2017 – Parma (IT).

Year 2018

  1. ECR 2018 (European Congress of Radiology) – E3 - ECR Academies – Topic 18 “Chest Imaging” – E3 118: “Lung cancer in the era of molecular oncology and immune therapy”, Lecture: “ALK-rearranged lung adenocarcinomas”, February 28-March 4 (European Congress of Radiology) - Vienna, Austria.
  2. Società Italiana di Radiologia Medica (SIRM): Course “Il nodulo polmonare: aggiornamenti nella diagnosi e nel management” – Sessione “La gestione del nodulo polmonare”, Lecture “Il nodulo polmonare: aggiornamenti nella diagnosi e nel management”, March 22, 2017 – Istituto Europeo Oncologico, Rozzano (MI), Italy.
  3. Course: “Il percorso del paziente con NSCLC avanzato con l’avvento dell’immunoterapia in I linea: difficolta e soluzioni nella pratica clinica quotidiana” – Session “Il percorso del paziente nella fase terapeutica”, Lecture” “Il momento della rivalutazione di malattia”, March 27, 2018 – Parma (IT).
  4. 99th Deutscher Röntgenkongress. Session “International Image Interpretation Quiz”, May 11, 2018 – Leipzig, Germany.
  5. Joint Meeting of European Society of Thoracic Imaging (ESTI) and European Society of Cardiovascular Radiology (ESCR), Session “COPD”, Lecture "Imaging work up in Lung Volume Reduction surgery", May 24-26 – Geneva, Switzerland.
  6. Course “Dibattito sulle Interstiiopatie Polmonari Fibrosanti”, Lecture “Imaging: Nuove Acquisizioni per la Corretta Interpretazione del Pattern Radiologico”, October 19-20, 2018 – Napoli (IT).
  7. Thoracic Imaging - European Respiratory Society (ERS), Lecture “Mediastinum” 25-27 October, 2018 – Barcelona (E) 
  8. Congresso Nazionale SIRM 2018 (Societa Italiana di Radiologia Medica); Lecture: “Modulazione della dose negli studi TC del torace: fino a che punto ci possiamo spingere?”. November 08-11, 2018 – Genova, Italy
  9. Course “Brixia 2018: Una giornata sull’Imaging del polmone”, Session “Il nodulo polmonare: solido, parzialmente solido e ground-glass”, Lecture “Imaging radiologico del nodulo parzialmente solido e ground-glass”, December 3, 2018 – Brescia (IT).
  10. Course “Brixia 2018: Una giornata sull’Imaging del polmone”, Session “Interstiziopatie fibrosanti: III parte (casistica ragionata)”, December 3, 2018 – Brescia (IT).
  11. Course “HRCT del torace: dalla tecnica alla refertazione”, Session “Focus sulle patologie fibrosanti del polmone”, Lecture “L’IPF e il rischio di tumore polmonare”, December 14-15, 2018 – Palermo (IT)

Year 2019

  1. Course “Le malattie polmonari diffuse fibrosanti” – Lecture: “Tecniche di Quantificazione”. January 25, 2019 – Milan (IT)
  2. ECR 2019 (European Congress of Radiology) 
    • POSTGRADUATE EDUCATIONAL PROGRAMME – Multidisciplinary Session (MS1): ”Lung Cance Team”, Lecture: “Imaging and staging”, February 27-March 3 (European Congress of Radiology) - Vienna, Austria
    • E3 - ECR Academies – Topic 18 “Chest Imaging” – E3 118: “Lung cancer in the era of molecular oncology and immune therapy”, Lecture: “ALK-rearranged and others mutations of lung adenocarcinomas”, February 27-March 3 (European Congress of Radiology) - Vienna, Austria
  3. Joint Meeting European Society of Thoracic Imaging (ESTI) and Fleischner Society.  Pre-congress Workshop, Session: “High Resolution CT”, Lecture: “GGO opaciLes and consolidaLon”. May 8, 2019 – Paris (FR)
  4. Joint Meeting European Society of Thoracic Imaging (ESTI) and Fleischner Society.  Session: “CT Lung Cancer Screening”, Lecture: “Risk models and biomarkers: Do they improve screening?”. May 9-11, 2019 – Paris (FR)
  5. International Associationf for the Study of Lung Cancer (IASLC) World Congress on Lung Cancer (WCLC) – September 7-10, Barcelona. 
    Pre-congress Workshop:
    • Session: “ Next Gen Imaging for Lung Cancer Screening How Do We Get There?”, Lecture: “Group Discussion with Interactive Questions”
    • Session “Functional Imaging Issues with Screening”, Lecture: “Experience with Imaging Platform Consistency”

Pre-congress Symposium: 

  • Session: “Global Prospective on Evolving Issues with CT Imaging in Lung Cancer Screening Populations”, Lecture: “Application of updated Fleischner Society Guidelines for Management of Lung Nodules”
  1. Symposium “NELSON, MILD und Co: Neue Erkenntnisse zum Lungenscreening”, Lecture “MILD, BioMILD results and further prospective” . October 24, 2019 – Universitätsspital Zürich (CH)

Year 2020

  1. Netherlands Heart Days 2020. Session 3 ”Lung Nodule Detection and Characterization”, Lecture “Baseline Nodules in Lung Cancer Screening”. January 16-18, 2020 – Nieuwpoort, Curaçao.
  2. Scandinavian MDCT course – Januar 22-24, 2020 in Larvik, Norway. 
    Lectures:
    • “Lung cancer: radiological management of advanced disease and radiological opportunities for early diagnosis”
    • “Smoking related lung diseases and radiological differential in dyspnea”
  3. Course: “PROGETTO PRIMATO. L’inquadramento del clinico e il contributo del radiologo su: BPCO, infezioni polmonari, interstiziopatie, noduli polmonari” – Lecture: “Il nodulo polmonare: facile rivelarlo... ma come gestirlo? Un aiuto dello screening”. January 23-25, 2020 – Milan 
  4. ECR 2020 (European Congress of Radiology) –  Session “NH 16 - Lung cancer screening implementation in Europe: is it inevitable?”, Lecture: “Lung cancer screening in Europe”, July 15-19 (European Congress of Radiology) – Online
  5. Webinar della Sezione di Radiologia Toracica della SIRM, Session"Lo screening del tumore polmonare: a che punto siamo?", Lecture: “Screening del tumore polmonare: evidenze dai trials “, September 14 – Online 
  6. Course: “Maratona di Pratica Clinica Respiratoria: 1° ROUND”, Session: “Modulo 4: Imaging”, Lecture: “Nodulo polmonare: facile rilevarlo...ma come gestirlo? Un aiuto dallo screening”, September 14-18 – Online
  7. Congresso Nazionale SIRM 2020 (Societa Italiana di Radiologia Medica); Session: “Deep learning – Il tumore polmonare: stato dell'arte e nuove prospettive”, Lecture: “Screening del tumore del polmone: pronti per partire?”. October 1-2 – Online and Rimini, Italy
  8. ECR 2020 Highlight Weeks: “Highlight Week Cardiovascular/Chest” September 29-30, 2020 – Online
    • Session: “C 19 - Structured reporting: how to provide the key information - application to thoracic imaging”, Lecture “Pulmonary nodules in lung cancer screening”
    • Session: “ESTI - Lung nodule management: case-based session”, Lecture “Solid nodule measurement, follow-up and criteria of positive screens”
    • Session: “Live Session: Chest”, Panelist.
  9. Journées Francophones de Radiologie Diagnostique & Interventionnelle – Medical Imaging International Congress, October 2-5 – Online and Paris, France
    • Session: “Management of the first wave of the COVID-19 epidemic, country experiences”, Lecture: “Expérience italienne”
    • Session in French: “Faire face à la pandémie de COVID-19 : évaluation internationale de la réponse de l'imagerie”, Lecture in French: “Réponse de l'imagerie dans la pandémie COVID en Italie”
  10. Prevent Cancer Foundation “Quantitative Imaging Workshop XVII: Leveraging CT to Accelerate Detection of Lung Cancer, COPD and Cardiovascular Disease”, Panelist in the Session: “Making Progress Toward a COPD & Small Lung Nodule Protocol”, October 29 – Online 
    https://web.cvent.com/event/465f1a7c-bf28-4ad8-829a-567b91870a43/summary )
  11. Webinar: “Pneumodicina 2020”, Session “Radiologia”, Lecture “Approccio quantitativo nelle malattie fibrosanti polmonari” – November 23, 2020 – Online and Milan, Italy
  12. European Society of Thoracic Imaging (ESTI) – Winter Course.  Session: “COVID and infection”, Lecture: “Thoracic Imaging in COVID-19”. December 10, 2020 – Online and Tromso, Norway
  13. Webinar: “Integrate 3.0 - Update sul trattamento del NSCLC in Stadio III”, Session “MODULO III - Valutazione della risposta e survivorship” – December 17, 2020 – Online and Genova, Italy
    • Lecture: “Valutazione della risposta al trattamento combinato”
    • Lecture: “Quale follow up dopo trattamento integrato?”

Year 2021

  1. ECR 2021 (European Congress of Radiology) –  Session “E3 919 - Low-dose thoracic CT: only screening for lung cancer?”, Lecture: “Overview of lung cancer screening activities in European countries”, March 3-7, 2021 – Online
  2. Case-based webinars della Sezione di Radiologia Toracica – Session “I Management del Nodulo Polmonare nella Pratica Clinica: Revisione di casistica”, Lecture “Nodulo Subsolido” – May 17, Online
  3. “NSCLS on Stage” – Lecture “Ruolo dell’Imaging Stadiativo”, April 28 and May 21, 2021 – Online
  4. IASLC 2021 CT Screening Symposium (International Association for the Study of Lung Cancer) – Session “Topic 3: Lung Cancer Screening implementation methodology”, Lecture: “Reconstruction protocols software vendor performance”, May 7-8, 2021 – Online
  5. Progetto SEGNO: La Semeiotica clinica e l’imaGiNg delle patOlogie respiratorie – Session “L’imaging toracico”, Lecture “Il nodulo polmonare: facile rilevarlo..ma come gestirlo? Un aiuto dallo screening” – September 9-10, Napoli
  6. International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2021 (WCLC2021). Session: “Screening and Early Detection in Lung Cancer”, Lecture: “Future Directions: Screening and AI” – September 8-14 – Online
  7. La Diagnosi Precoce del Tumore Polmonare Tramite TC a Bassa Dose: il Progetto PEOPLHE, Session “La Diagnosi Precoce del Tumore Polmonare”, Lecture “Il Nodulo Polmonare” – October 2, Catania
  8. Congresso Congiunto delle Sezioni di Radiologia Toracica, Radioprotezione e Radiobiologia con il Gruppo Regionale SIRM Lombardia.
    Convegno Nazionale della Sezione di Radiologia Toracica – Session “Screening del Tumore Polmonare”, Lecture “I risultati dei trials dell’ultimo decennio” – October 8-9, Milan
  9. Maratona di Prarica Clinica Respiratoria: 2o Round. Session: “L’Imaging del Torace: Le Patologie Respiratorie Sotto la Lente”, Session “Il nodulo polmonare: facile rilevarlo..ma come gestirlo? Un aiuto dallo screening” – October 7-10, Viareggio
  10. Quantitative Imaging Workshop XVIII: Optimizing Thoracic Imaging to Detect and Manage Early Lung Cancer and COPD (Prevent Cancer Foundation) – Session “Lung Cancer & Copd Imaging – Technical Imaging Guidance”, Lecture “Improving CT Lung Cancer Screening Through Image Quality Optimization” – November 4-5, Online
  11. European Society of Thoracic Imaging, Section of Lung Cancer Screening: Workshop “Hans-on” for the sue of computer aided detection for volume segmentation of lung nodules – October 13, Online
    Role: Master Tutor
  12. Corso Teorico-Pratico “Dalle basi Teoriche Alla Refertazione Dell’Imaging Toracico”, Module “I Tumori del Torace”, November 10-11, Parma – Lectures:
    • “L’imaging del tumore polmonare nell’era della terapia personalizzata”
    •  “La risposta al trattamento”
    • “Come lavorare nello screening del tumore polmonare”
    • “I tumori della parete toracica”

Congresses/Courses AS FACULTY: ModeratorYear 2015

  1. Joint Meeting European Society of Thoracic Imaging (ESTI) and Fleischner Society.  Session” Controversies in thoracic oncology”. June 4-6, 2015 – Barcelona (ES).
  2. HRCT delle malattie polmonari diffuse. Sezione di Radiologia Toracica, Società Italiana di Radiologia Medica (SIRM). October 9-10, 2015 - Rovereto (IT).

Year 2016

  1. ECR 2016, March 2-6 (European Congress of Radiology) - Vienna, Austria. Moderator in the Scientific Session “SS 604 (Topic: Chest): Spectral CT, nodules, fibrosis and emphysema”.

Year 2017

  1. 4th World Congress of Thoracic Imaging (WCTI), Session “Quantitative, Emphysema, Infection”, June 18-21 – Boston (MA), USA.
  2. Associazione Italiana Pneumologi Ospedalieri (AIPO): Course “Tubercolosi, da stop TB a end TB”, Session “Aspeti Clinici e Diagnostici”, November 9 – Parma (IT). 

Year 2018

  1. Società Italiana di Radiologia Medica (SIRM): Course “Il nodulo polmonare: aggiornamenti nella diagnosi e nel management” – Sessione “Il nodulo polmonare: oltre limaging radiologico”, Invited lecture “Il nodulo polmonare: aggiornamenti nella diagnosi e nel management”, March 22, 2017 – Istituto Europeo Oncologico, Rozzano (MI), Italy
  2. Checklist di refertazione dell’imaging testa-collo, May 4 2018 – Parma, Italy
  3. Joint Meeting of European Society of Thoracic Imaging (ESTI) and European Society of Cardiovascular Radiology (ESCR), Scientific Session "Lung cancer", May 24-26 – Geneva, Switzerland.
  4. Congresso Nazionale SIRM 2018 (Societa Italiana di Radiologia Medica); Scientific Session: “Miscellanea”. November 08-11, 2018 – Genova, Italy

Year 2019

  1. ECR 2019, February 28 – March 3 (European Congress of Radiology) - Vienna, Austria. Moderator in the Refresh Course (RC 504) “Pulmonary neuroendocrine proliferations and neoplasms” within the Postgraduate Educational Programme. 
  2. European Respiratory Society (ERS) International Congress 2019 Madrid IFEMA, Spain, 28 September – 2 October 2019. Session: “Lung Cancer Grand Round”

Year 2020

  1. Netherlands Heart Days 2020, January 16-18 – Nieuwpoort, Curaçao. Moderator in “Session 5 – B3 Hot Topics” in Lung Cancer Screening (Speakers: Oudkerk M, Baldwin DR, Vliegenthart R).
  2. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “Solid nodule measurement and follow up criteria for positive screens”. December 14, 2020 – Online

Year 2021

  1. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “Subsolid nodules evaluation and follow‐up, criteria of positive screens”. January 18, 2021 – Online
  2. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “How to evaluate the coronary arteries and management of ancillary findings”. February 22, 2021 – Online
  3. European Respiratory Society (ERS) International Congress 2021.
    Session: “Imaging in COVID-19”. September 5-8, 2021 – Online
  4. European Society of Thoracic Imaging (ESTI) – Winter Course. Session “Nodules and lung cancer screening” – December 9-10, Online

Congresses/Courses AS FACULTY: Scientific CommitteeYear 2018

  1. European Congress of Radiology (ECR) 2018, February 28-March 4 – Vienna, Austria
    Member of the Scientific Subcommittee "Chest".

Year 2019

  1. European Congress of Radiology (ECR) 2019 February 27-March 3 – Vienna, Austria
    Member of the Scientific Subcommittee "Chest".

Year 2020

  1. European Congress of Radiology (ECR) 2020 March 11-15 – Vienna, Austria
    Member of the Scientific Subcommittee "Chest".

Year 2021

  1. International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2021 (WCLC2021) September 8-14 – Online
    Invited Abstract Reviewer (March 26, 2021)

Year 2022

  1. International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2022 (WCLC2022) August 6-9 – Vienna, Austria

Chair for the “Early Detection and Screening” track

_ _ _ _ _ _ _

 

Updated October 2021

Da Lunedì a Venerdì, su appuntamento

Anno accademico di erogazione: 2021/2022

Anno accademico di erogazione: 2020/2021

Anno accademico di erogazione: 2019/2020

Anno accademico di erogazione: 2018/2019

Anno accademico di erogazione: 2017/2018

Anno accademico di erogazione: 2016/2017

Docente di riferimento

Linee di ricerca

Thoracic Imaging --- Lung Cancer Screening by Low-Dose Computed Tomography --- Radiomics

Pubblicazioni

Orcid

https://orcid.org/0000-0002-2538-7032

Other

Clinical activity at Unit "Scienze Radiologiche", with specific focus on thoracic disease

Clinical activity at Unit "Radiologia di Emergenza-Urgenza", with specific focus on emergency

Radiology staff at the multidisciplinary meetings of "Oncology" and "Thoracic disease"

Contatti

Ubicazione dell'ufficio

Scienze Radiologiche, Pad. Barbieri, Ospedale Universitario di Parma

Via Gramsci 14

43126, Parma (IT)